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The gram negative bacterium Shigella flexneri is an etiological agent of bacillary 
dysentery, and causes destruction of the human intestinal epithelium.  S. flexneri is primarily 
transmitted via the fecal-oral route to its primary infective site in the colon.  The bacterium 
invades and replicates within colonic epithelial cells, ultimately ulcerating the mucosal 
epithelium. To successfully establish infection, S. flexneri must quickly adapt to different 
environments in the host, including adjusting metabolism in response to changes in available 
carbon sources.  In this study, the importance of the glycolytic and gluconeogenic pathways 
in S. flexneri pathogenesis was examined.   
The metabolic regulators CsrA and Cra reciprocally regulate the glycolytic and 
gluconeogenic pathways. The post-transcriptional regulator Cra activates expression of genes 
involved in gluconeogenesis and represses glycolysis.  Conversely, CsrA activates glycolysis 
and represses gluconeogenesis.  The absence of Cra increased S. flexneri attachment and 
 vii 
invasion of cultured epithelial cells.  In contrast, the csrA mutant was significantly impaired 
in both adherence and invasion. Both the csrA and cra mutants formed small, turbid plaques, 
suggesting that both regulators are required for plaque formation. The opposing phenotypes 
of the csrA and cra mutants suggested a correlation between invasion and glycolysis. 
The role of glycolysis in S. flexneri pathogenesis was confirmed by directly 
examining the first committed step in the pathway.  The glycolytic enzyme 
phosphofructokinase I (PfkI, encoded by pfkA) is repressed by Cra and activated by CsrA.  
Glycolysis was critical for S. flexneri pathogenesis, as a mutation in pfkA rendered the 
bacterium noninvasive.  The invasion defect of the csrA and pfkA mutants was due to reduced 
expression and secretion of the Shigella invasion plasmid antigen (Ipa) effectors. Expression 
of the master virulence regulators virF and virB was significantly reduced in the pfkA mutant, 
and is the principle reason for decreased invasion.  The data presented show that glycolysis is 
required for invasion, but that plaque formation requires both glycolysis and 
gluconeogenesis.  Because expression of the master virulence regulators is repressed in the 
pfkA mutant, S. flexneri may use carbon as an environmental regulator of virulence gene 
expression. 
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1. Shigella flexneri pathogenesis 
 
The gram negative pathogen Shigella causes bacillary dysentery, or shigellosis, in 
humans and higher order primates. Shigella invades and destroys the colonic epithelium 
leading to desquamation of the epithelial layer and subsequent ulceration of the colon.  
Destruction of the colonic epithelium and the inflammatory response result in 
characteristic symptoms of the disease, including profuse, bloody stools, fever and 
abdominal cramps.   The bacterium is primarily transmitted via the fecal-oral route, and 
Shigella infections occur primarily in developing countries where dissemination of the 
bacterium is augmented by poor sanitation.  Over 165 million cases of shigellosis occur 
annually, resulting in approximately 1.1 million deaths (94).   
 
The genus Shigella is divided into four species, Shigella sonnei, Shigella boydii, 
Shigella dysenteriae and Shigella flexneri, which are further divided into 13 serotypes 
based on O-antigen variation (56).   S. flexneri is endemic in developing countries and 
causes the most communicable form of bacillary dysentery, but the 2a serotype 
predominates in industrialized countries (56).  Shigella is closely related to Escherichia 
coli, and these two bacteria are generally thought to comprise a single species (67). 
Genetic analysis suggests that Shigella arose by convergent evolution from several E. coli 
strains. E. coli and Shigella share common housekeeping genes, including those for 
nutrient acquisition and central carbon metabolism (145).   Enteroinvasive E. coli (EIEC) 
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and S. flexneri are very similar, both in disease pathology and virulence mechanisms. 
Shigella and EIEC have acquired a 220-kb virulence plasmid encoding the mxi-spa type 
III secretion system and associated effectors which allow for invasion, replication and 




Shigella is primarily transmitted by the fecal-oral route and enters the host by 
ingestion of contaminated food or water.  The bacterium then travels through the host 
gastrointestinal tract to its infective site in the large intestine.  In the primary stages of 
infection, S. flexneri invades the colonic epithelial cells via the basolateral face (Fig. 1) 
(85).  M cells, which sample lumenal contents, transcytose Shigella and deposit the 
bacterium into an intraepithelial pocket (Fig. 1, steps 1-2) (141).  It is here that circulating 
macrophages may phagocytose S. flexneri.  S. flexneri ensures its survival by rapidly 
inducing apoptosis of the macrophage (Fig.1, step 3) (149).   
After release from the macrophage, S. flexneri weakly adheres to the basolateral face 
of the epithelial cell and induces massive cytoskeletal rearrangements (Fig. 1, step 4). By 
uncoupling the host membrane from the cytoskeletal architecture, S. flexneri is able to 
promote its uptake in a process similar to macropinocytosis (132). After engulfment by 
the host cell, S. flexneri creates a pore in the resulting vacuole, thereby releasing the 
bacterium into the host cell cytosol (Fig. 1, step 5).  Once the bacterium has escaped the 
vacuole, S. flexneri replicates freely within the host cytosol, and spreads intracellularly 
(Fig. 1, steps 6-7). 
By nucleating actin at one pole, S. flexneri creates a propulsive force that pushes the 
bacterium within the host cell (40).  Eventually, this movement results in a protrusion of 
the bacterium into the neighboring cell that is subsequently engulfed.  S. flexneri again 
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disrupts the resulting vacuole, thereby gaining access to the host cytosol.  By replicating 
within and spreading between the epithelial layer, S. flexneri is protected against the host 
immune response.  
As the bacterium spreads between the mucosal layer, tight junctions are disrupted, 
thereby allowing lumenal Shigella to access the basolateral face of the colonic epithelia. 
Persistence of the bacterium within the colon recruits polymorphonucleocytes (PMN), 
which also infiltrate the tight junctions, and further disrupt the monolayer.  This 
destruction of the monolayer allows further dissemination of the bacterium to the 





Figure 1.  Model of S. flexneri pathogenesis.   
After traveling to the colon, the bacterium is endocytosed by M cells in the colonic 
epithelial layer and subsequently deposited in an intraepithelial pocket [1].  Macrophages 
phagocytose S. flexneri [2], and the bacterium ensures its survival by inducing apoptosis 
of the macrophage [3].  S. flexneri attaches to the basolateral face of the colonic epithelial 
cell [4] and induces its own uptake in via macropinocytosis.  The engulfed bacterium is 
enveloped in a vacuole [5], which S. flexneri subsequently lyses.  Next, S. flexneri 
replicates within the host cytosol, and spreads to adjacent epithelial cells using an actin-
based motility and the bacterial protein IcsA [6].  This movement results in a protrusion, 
which is engulfed by the neighboring cell [6], and the bacterium lyses the double 
membrane, thereby allowing the process of intracellular replication and intercellular 



















Figure 2: Organization of the 31-kb entry region of the S. flexneri virulence plasmid.   
The genes located in this region are necessary for invasion by S. flexneri and are coded 
according to their function.  VirB and VirF activate transcription at the sites indicated.  
Adapted from Dorman and Porter (29) and Schroeder and Hilbi. (120). 
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3. Factors involved in S. flexneri pathogenesis  
3.1 VIRULENCE-PLASMID ENCODED FACTORS 
The genes necessary for bacterial entry, survival and spread are encoded on a 31-kb 
entry region on the virulence plasmid (74, 119).  This entry region is comprised of 34 
genes which are organized in two clusters (Fig. 2) and includes the necessary genes for 
the type III secretion apparatus (mxi-spa) and its secreted effectors (ipa, ipg, virA), 
chaperones (ipgA, ipgC, ipgE and spa15), and transcriptional activators (120).  
Additional factors necessary for virulence are encoded elsewhere on the virulence 
plasmid.   
The Ipa (invasion plasmid antigen) proteins IpaB, IpaC and IpaD have a central role 
in S. flexneri invasion.  Prior to contact with the host cell, IpaB and IpaC are bound to 
their chaperone protein IpgC within in the bacterial cytosol. The adapter protein IpaD is 
positioned at the tip of the type III needle, where it acts to regulate secretion of IpaB and 
IpaC (34).  Bile salts induce the presentation of IpaB at the needle tip, and IpaB binds to 
CD44 receptors present in lipid rafts in the host cell membrane (34, 66, 96). Activation of 
the needle tip complex by the lipid raft component sphingomyelin results in recruitment 
of IpaC to the needle tip and subsequently promotes invasion (33). IpaB and IpaC form a 
translocon pore in the eukaryotic cell, through which additional effector proteins can 
enter.  These effectors, including IpaA, IpgD and VirA, are responsible for the membrane 
rearrangements necessary to induce engulfment of the bacterium (95).  Also included in 
the entry region is icsA.  IcsA localizes preferentially to the old pole of the bacterium, 
where it nucleates actin to propel the bacterium inter- and intracellularly (40).    
The transcriptional activators VirB and MxiE are also encoded within this region of 
the virulence plasmid.  The combination of environmental cues present in the mammalian 
intestine, including pH (103), osmolarity (11), and temperature (129, 131), induce 
expression of the master virulence regulator VirF.  VirF, in turn induces expression of 
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both icsA and virB (Figs. 2, 3) (115, 130). The transcriptional regulator VirB is a member 
of the ParB family of partitioning proteins, and directly activates transcription of genes 
within the entry region (1).  
The third regulator, MxiE, is responsible for activation of the second wave of 
effectors needed by intracellular bacteria (63).  Effector secretion via the type III 
secretion system regulates the activity of MxiE.  After IpaB and IpaC are secreted, their 
chaperone protein IpgC acts as a co-activator of MxiE (76). Additionally, the effector 
protein OspD1 and its chaperone Spa15 also regulate MxiE activity.  Inside the bacterial 
cytosol, OspD1-Spa15 binds to MxiE, and prevents MxiE from binding to IpgC.  
Secretion of OspD1 alleviates MxiE repression, allowing activation of MxiE by IpgC 
(97).   In this fashion, activity of MxiE is then regulated by bacterial location, as OspD1 
is secreted by intracellular Shigella.  
 
3.2 CHROMOSOMALLY-ENCODED FACTORS 
During the course of infection, Shigella faces varying environmental conditions. 
Expression of the plasmid-encoded virulence genes is maximally induced in response to 
environmental signals in the mammalian intestine (11, 103, 129, 131). Temperature 
appears to be a principal environmental stimulus, and S. flexneri is noninvasive at 30°C 
(75).  Expression of virF, virB and the ipa-mxi-spa type III secretion system is thermally 
inducible.  Growth at 37°C only increases expression of virF two-fold relative to its 
expression level at 30°C.  However, expression of the downstream regulator virB 
increases ten-fold under permissive conditions, and expression of the effector gene icsB 
increases 100-fold (103).  Although regulation of virF expression is lax, tight control of 
virB and ipa-mxi-spa expression ensures that the structural components necessary for 
invasion will only be produced under the appropriate conditions (103).    
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The nucleoid-associated proteins Fis (factor for inversion stimulation), IHF 
(integration host factor) and H-NS (heat-stable nucleoid structuring protein) have a 
central role in thermoregulation of expression from the virulence plasmid.  At non-
permissive temperatures (<32°C), H-NS binds to both the virF and virB promoters and 
significantly inhibits transcription of both (Fig. 3) (10).  At 37°C, the topology of the 
promoters changes such that H-NS repression is overcome.  Fis and IHF then bind to the 
virF promoter and activate transcription. The level of VirF is also affected by the levels 
modified tRNAs. The gene products of tgt and miaA synthesize nucleosides queosine (Q) 
and 2-methyltio-N6-isopentenyladenosine (ms2i6A37), respectively.   The absence of 
either tgt or miaA causes a reduction in the amount of VirF, presumably due to poor 
translation of the virF mRNA (32).  
 The mechanism of thermal regulation of virB expression has been well studied.  
Although some VirF is present at 30°C, it is unable to activate expression of virB at this 
temperature.  The accessibility of the virB promoter is greatly influenced by supercoiling 
around this region.  Higher temperatures lead to a reduction in linking number at the virB 
promoter, and it is presumed that this modification in promoter topology allows for VirF-
mediated activation of virB. The alleviation of H-NS repression at the virB promoter 
allows for binding by VirF and IHF (104), thereby activating the virulence gene 
expression cascade.  VirF binds base-pairs -117 to -17 on the virB promoter, but it is 
unclear if VirF activates transcription by directly contacting RNA polymerase or if VirF 
is required for recruitment of RNA polymerase to the promoter (131).   
Both pH and osmolarity influence virulence gene expression via two-component 
systems.  The ompB locus encodes the EnvZ histidine kinase and OmpR response 
regulator, which modulate porin expression in response to osmolarity fluctuations (122).  
Growth in low osmolarity medium represses expression of genes in the entry region, but 
this regulation does not supersede thermoregulation (103).  Deletion of the ompB locus 






Figure 3:  Environmental factors regulate expression of virF and virB.    
 (A) Expression of virF is repressed by H-NS, and activated by Fis, IHF and 
phosphorylated CpxR (CpxR~P).  Translation of the virF mRNA is enhanced by the 
tRNAs made by MiaA and Tgt.  (B) Transcription of virB is inhibited by H-NS. 
Temperature, osmolarity and pH increase the supercoiling around the virB promoter.  
This reduction in linking number promotes VirF-mediated activation of the virB 
promoter. VirF binding to the virB promoter could recruit or stimulate activity of RNA 




the OmpR-activated porin OmpC decreases S. flexneri virulence in vitro (12). However, 
no direct role has been identified for OmpR in expression of plasmid-encoded virulence 
genes. 
In S. sonnei, the CpxA-CpxR two-component system regulates virulence gene 
expression in response to changes in pH (89, 90).  Expression of virF is lower at pH 6.0 
versus pH 7.4.  Growth at the higher pH induces autophosphorylation of the CpxA 
histidine kinase. CpxA then donates the phosphate group to its cognate response regulator 
CpxR.  Binding of phospho-CpxR upstream of the virF promoter activates virF 
expression (Fig. 3).  Although this pH regulation was characterized in S. sonnei, the 
CpxA-CpxR two-component system has been identified in Shigella spp., suggesting that 




4. Role of lipopolysaccharide in S. flexneri virulence 
 
The gram negative outer membrane is an effective barrier that protects the bacterium 
against several harmful agents, including cationic antimicrobial peptides, detergents, bile 
salts and host defense mechanisms (93).  The outer membrane is an asymmetric bilayer, 
with phospholipid comprising the inner face, and lipopolysaccharide (LPS) as the outer 
face. LPS is composed of three distinct regions: lipid A, core polysaccharide and O-
polysaccharide (Fig. 4).   
S. flexneri lipid A is comprised of a glucosamine disaccharide modified with six acyl 
chains; the primary acyl chains are ligated to the 2, 3, 2’ and 3’ positions of the sugar 
molecules, and the secondary acyl chains are conjugated at the 2’ and 3’ primary chains 
(41).  The addition of the secondary acyl chains requires two acyltransferases, LpxL, 
which adds laurate to the 2’ primary chain, and MsbB, which adds myristate to the 3’ 
primary chain.  S. flexneri is unique in that it contains two non-redundant msbB genes.  
MsbB1 is present on the chromosome, while MsbB2 is encoded on the virulence plasmid 
(26).  An S. flexneri msbB1msbB2 double mutant was significantly impaired in 
destruction of the epithelium in a rabbit model of infection (26). It is thought that both 
myristoyl transferases may be required for S. flexneri survival in vivo, as increased hexa-
acylation of lipid A could protect the bacterium from antimicrobial peptides (41). 
 The LPS core region can be divided into the inner (lipid A-proximal) and outer core 
regions. S. flexneri 2a core belongs to the R3 core type, which is found in several 
pathogenic E. coli species (38).   Phosphorylation of the core heptose residues plays an 
important role in maintaining the barrier function of the outer membrane (93).  The core 




Figure 4:  Structure of S. flexneri 2a lipopolysaccharide.    
Abbreviations: Kdo: 2-deoxy-D-manno-oct-2-ulsosonic acid, Hep: heptose, P: 
phosphoryl, PtEN: phosphatidylethanolamine, Glc: glucose, Gal: galactose, GlcNAc: N-
acetyl-glucosamine, Rha: rhamnose.  Dotted lines indicate substoichiometric subsitutions, 
as HepIII is conjugated to GlcNAc only when HepII is not phosphorylated.  GlcII was 
identified as the O-polysaccharide ligation site by Kaniuk et al.  (64).   
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membrane proteins.  Most genes required for biosynthesis of the core polysaccharide are 
encoded on the chromosome. wabB (rfbU), however, is encoded on the virulence plasmid 
in both EHEC and S. flexneri 2a (64).   wabB encodes a transferase responsible for the 
addition of N-acetyl glucosamine (GlcNAc) to heptose III in the inner core.  In EHEC, 
expression of wabB is thermoregulated, with maximal expression occurring at 24°C as 
compared to 37°C (38). The significance of wabB on the virulence plasmid has not been 
experimentally determined, but may indicate coordination of LPS modifications with 
virulence.  
The O-polysaccharide side chain shows wide degrees of heterogeneity, giving rise to 
different serogroups of S. flexneri.  In S. flexneri 2a strains, the O-antigen repeat unit is 
composed of a tri-rhamnose-N-acetyl-glucosamine tetrasaccharide, in which the first 
rhamnose residue is generally glucosylated (Fig. 4).   
The presence of O-antigen has a significant effect on S. flexneri pathogenesis. A 
mutation in rfbD (blocking dTDP-rhamnose synthesis) is invasive and able to replicate 
intracellularly in an epithelial cell monolayer, but is impaired in intercellular spread 
(134).  In this mutant, IcsA localizes along the length of the cell body, versus the unipolar 
localization seen in wild type (134).  This heterogeneous pattern of IcsA localization 
subsequently leads to F-actin polymerization around the perimeter of the cell.  A similar 
pattern of aberrant IcsA localization was seen in the rfaL (O antigen ligase) and rfc (O-
antigen polymerase) mutants (117).  Like the rfbD mutant, the rfaL and rfc mutants were 
impaired in intercellular spread. Sandlin et al. (117) postulated that polar localization of 
IcsA is needed to generate the propulsive force needed for intracellular spread.  Thus 
diffuse IcsA localization in the rfbD, rfaL and rfc mutants fails to generate uniformed, 
directional F-actin polymerization needed for cell-cell spread.  In addition to its role in 
mediating IcsA localization, the O-antigen is also needed for S.flexneri resistance to 
serum (54).   
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The above studies were performed using a nonpolar monolayer of epithelial cells. In a 
polarized epithelial cell model, rfc and rfaL mutants are severely impaired in invasion 
(65).  This suggests that the entry requirements are different in the two cell types.  Kohler 
et al. (65) postulate that at the basolateral membrane, LPS may be the primary adhesin 
and may also serve to stimulate the proinflammatory events needed for PMN migration.  
S. flexneri has two genes that control the length of LPS.  wzzSf is chromosomally 
encoded and is responsible for the shorter (mode A) distribution of 11-17 O-antigen 
repeat units. A second gene, wzzpHS2 encodes a much longer distribution (>90 repeat units) 
termed mode B.  wzzpHS2 is encoded on pHS2, a 3 kb plasmid found in several S. flexneri 
2a isolates (124). The proportion of the mode A and mode B distributions is regulated in 
response to growth rate. Although the amount of the shorter, mode A pattern appears to 
be constant, the amount of mode B increases as the bacteria enter stationary phase (20).  
Temperature also affects LPS patterns, as growth of S. flexneri at 30°C increases the ratio 
of long chains relative to short chains, as compared to bacteria grown at 37°C (136).  
Surprisingly, the O-antigen pattern does not appear to change inside the host cell, as 
compared to bacteria grown in vitro (136).   
The O-antigen distribution pattern is also critical for pathogenesis. Mutations in either 
wzzSf or wzzpHS2 disrupt the modal distribution of O-antigen.  A wzzSf mutant makes 
shorter O-antigen chains (1-10 repeat units) than wild type along with the longer mode B 
O-antigen chains.  A wzzSf  mutant is less invasive than wild type, and aberrant IcsA 
localization inhibits intercellular spread in this strain (54, 134). The absence of wzzpHS2 
prevents the synthesis of the longer mode B O-antigen chain, and thus a wzzpHS2 mutant 
only makes the shorter mode A distribution.  The S. flexneri wzzpHS2 was invasive and able 
to spread intercellularly. However, this mutant was sensitive to killing by serum.  These 
two O-antigen lengths are therefore needed to balance exposure of the bacterial proteins 




In addition to regulating the modal distribution of O-antigens, S. flexneri also changes 
the length of the LPS molecule by glucosylation of the O-polysaccharide.  This 
glucosylation is mediated by the phage genes gtrABX (3). Glucosylation of the O-
polysaccharide is thought to compact the molecule. This transition shortens the overall 
length of LPS, thereby increasing exposure of the type III needle relative to the outer 
membrane without affecting the barrier function of the outer membrane (144).   
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5. Survival in the lumen and intracellular metabolism 
 
During infection, S. flexneri encounters several unique microenvironments and thus 
must adapt to these environments to persist in the host. Most intestinal bacteria require a 
fermentable carbon source for growth and thus it is assumed that carbohydrate 
metabolism is required for colonization (99).  Regulation of carbon metabolism has been 
shown to be important for colonization and infection by several enteric bacteria.   
 
Although the mammalian GI tract is rich in carbohydrates, these resources are often 
consumed by the established intestinal flora.  Freter’s nutrient-niche hypothesis proposes 
that nutrient availability defines distinct niches within the intestine (68). Theoretically, 
each niche is occupied by one species that preferentially consumes a unique metabolite, 
and the concentration of that metabolite ultimately limits population size. Chang et al.  
expanded on this theory to suggest that differences in metabolite availability and the 
commensal population may affect the establishment of pathogenic bacteria within the 
host (21).   
 
Within the gastrointestinal tract, enterohemmoragic E. coli (EHEC) lives a 
scavenging lifestyle, co-metabolizing several carbon sources not consumed by the 
commensal E. coli strains with which it must compete, including hexuronates, galactose, 
mannose and ribose (35).  When the mouse intestine is precolonized with commensal E. 
coli, EHEC strain EDL933 uses glycolytic carbon sources for initial growth, but relies on 
both glycolytic and gluconeogenic carbon sources for persistence (80).   Internal 
glycogen stores are also a crucial carbon source for E. coli colonization (35).  The strong 
genetic similarity between S. flexneri and E. coli suggests that S. flexneri may adopt a 




S. flexneri is among a small group of pathogens specially adapted for growth in the 
eukaryotic cytosol.   Although prevailing thought suggests the cytosol is a nutrient rich 
environment, non-cytosolic pathogens were unable to replicate when microinjected into 
the mammalian cytosol (39).  This suggests that S. flexneri and other cytosolic pathogens 
are specially adapted to thrive in this environment. To better understand the metabolic 
profile of intracellular S. flexneri, microarray analysis and GFP-promoter fusions have 
been employed.   
 
Microarray analysis of intracellular S. flexneri revealed differential regulation of over 
one-quarter of the genome, including several genes involved in carbon uptake and 
metabolism (73).  Notably, uphT, encoding a hexose phosphate transporter, was 
significantly upregulated inside the cytosol (73, 111).  Although these data suggest that S. 
flexneri may consume phosphorylated carbon sources intracellularly, microarray analysis 
also revealed downregulation of several glycolytic and respiratory genes (73). 
Furthermore, deletion of uhpT had no effect on S. flexneri virulence in vitro (111). S. 
flexneri may therefore use several carbon sources while inside the host cytosol, or may 
use hexose phosphates upon entry but switch to alternate carbon sources during the later 
stages of infection.  Data gathered from both lumen and cytosol point to carbon as an 
important nutrient for S. flexneri pathogenesis. Variations in carbon source or its 
availability may act as an environmental regulator of virulence gene expression.  
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6. Central Carbon Metabolism 
The central metabolic pathways in prokaryotes include the glycolytic (Embden-
Meyerhoff-Parnas, EMP), Entner-Doudoroff and Pentose Phosphate pathways (Fig. 5).  
These metabolic pathways convert carbohydrates, carboxylic acids and acetic acid into 
energy and precursor molecules for biosynthetic pathways within the cell.   
 
6.1 GLYCOLYSIS AND GLUCONEOGENESIS 
Carbohydrate metabolism via glycolysis provides a significant portion of cellular 
energy.  Through a series of ten reactions, the glycolytic pathway degrades glucose into 
two molecules of pyruvate and simultaneously generates a net of two ATP molecules 
(Fig. 5).  The glycolytic pathway can be divided into two major stages.  In the first stage, 
glucose is phosphorylated twice and converted into fructose 1,6 bisphosphate.  This 
initial stage requires the input of two molecules of ATP to effectively prime the second 
stage.  
 
 In the second half of glycolysis, fructose 1,6 bisphosphate is cleaved by fructose 1,6 
bisphosphate aldolase to yield glyceraldehyde 3 phosphate (G3P) and dihydroxyacetone 
phosphate (DHAP).  G3P is then oxidized by NAD+ and phosphorylated yielding 1, 3 
bisphosphoglycerate.  High-energy phosphate is donated to ADP to generate ATP via 
substrate level phoshorylation.  3-phosphoglycerate is converted to 2-phosphoglycerate, 
and then dehydrated forming phosphoenolpyruvate (PEP).  A second substrate 
phosphorylation event completes glycolysis, generating a second molecule of ATP and 






Figure 5.   Central metabolic pathways in Escherichia coli and Shigella flexneri.   
 The Entner-Doudoroff and Pentose Phosphate pathways diverge from glycolysis via 6-
phosphogluconate.  Gluconeogenesis is essentially a reversal of the glycolytic pathway, 
with the exception of the irreversible steps of fructose-6-P phosphorylation and 
phosphoenolpyruvate dephosphorylation (see text for details).  The three pathways shown 
ultimately generate pyruvate. Enzymes that catalyze the reactions are noted in italics, and 
are those used in E. coli. Abbreviations: DHAP, dihydroxyacetone phosphate; KDPG, 2-
keto-3-deoxy-6-phosphogluconate; TK, transketolase; TA, transaldolase. 
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Several of the glycolytic intermediates serve as biosynthetic precursors for amino 
acid, lipopolysaccharide, and nucleotide biosynthetic processes.  In the absence of 
carbohydrate carbon sources, these precursors are made from other sources via 
gluconeogenesis.  Gluconeogenesis generally uses glycolytic enzymes, but the reactions 
that generate fructose 1,6 bisphosphate (phosphofructokinase, pfkA, pfkB), and pyruvate 
(pyruvate kinase, pykF) are energetically irreversible.  Therefore, these reactions are 
replaced in gluconeogenesis with energetically favorable reactions, specifically those 
catalyzed by fructose bisphosphatase (fbp), and phosphoenolpyruvate synthase (ppsA) 
(Fig. 5). In this fashion, these irreversible steps also allow for control of carbon flow 
directionality. 
 
6.2 GLYCOGEN METABOLISM 
 
Glycogen is an important stored nutrient source for bacteria under starvation 
conditions, and promotes bacterial viability under nutrient-limiting conditions.  In E. coli, 
glycogen is composed of glucose linked by 95% α 1,4 linkages and only 5% α 1,6 
branched glucosyl linkages (105).  Synthesis of glycogen is stimulated under conditions 
where carbon sources are abundant but other nutrients are limiting.  Three enzymes are 
required for glycogen biosynthesis: ADP-glucose phosphorylase, glycogen synthase and 
branching enzyme (Fig. 5).  The ADP-glucose phosphorylase, encoded by glgC, 
generates ADP-glucose from glucose-1-phosphate and ATP.  GlgA, the glycogen 
synthase, extends the glycogen molecule by transferring glucosyl units from ADP-
glucose to the growing polymer. Branching of glycogen is accomplished by the GlgB 
branching enzyme, which creates the α 1, 6 glycosidic linkages (105).  GlgS is also 
required for glycogen biosynthesis, although it has no defined role in the biosynthetic 
reactions.  Under carbon-limiting conditions, glycogen serves as an important internal 
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carbon source.  Glycogen degradation is mediated by GlgP phosphorylase, which 
removes glucose from the glycogen molecule, and the GlgX debranching enzyme (105).   
The role of glycogen metabolism in virulence is still unclear (14, 77). However, 
recent studies have shown that this polymer is important for establishment and 
maintenance of E. coli in the host.  The absence of the glycogen biosynthetic proteins 
GlgA or GlgS severely impaired establishment of both commensal and enterohemorragic 
E. coli within the mouse intestine (60).   Similarly, deletion of the glycogen degradative 
enzyme GlgP caused defects in maintainance of commensal and enterohemorragic E. coli 
within the mouse (60).  These data suggest that glycogen is an important source of carbon 
within the lumen, and may provide a nutritional buffer for the bacterium while it 
scavenges for resources within the host. 
 
6.3 PENTOSE PHOSPHATE PATHWAY 
The pentose phosphate pathway can be used alongside the glycolytic or Entner-
Doudoroff pathway.  In this pathway, glucose-6-phosphate is oxidized to 6-
phosphogluconate, and then subsequently oxidized to ribulose-5-phosphate and CO2 (Fig. 
5). Next, ribulose-5-phosphate is converted to a mixture of 3 through 7 carbon sugar-
phosphates.  A transketolase reaction catalyzes the transfer of two-carbon ketol groups 
while the transaldolase transfers a three-carbon group from sedoheptulose-7-phosphate to 
glyceraldehyde-3-phosphate.  The pentose phosphate pathway serves both catabolic and 
anabolic functions within the cell.  The NADPH produced during the oxidation steps is 
an important source of electrons for reduction of molecules during biosynthetic reactions.  
Additionally, the erythrose and ribose intermediates can be used to make aromatic amino 
acids and nucleic acids, respectively.  The pentose phosphate pathway also allows the cell 
to use pentoses as either a primary carbon source or for the production of hexose sugars.  
The pentose phosphate pathway was shown not to be essential for colonization of the 
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mouse intestine by commensal E. coli (21). However, expression of genes in the pentose 
phosphate pathway were significantly upregulated during intracellular growth of the 
intracellular pathogen Listeria monocytogenes, suggesting that this pathogen primarily 
uses this pathway for sugar metabolism in the intracellular environment (62) 
 
6.4 ENTNER-DOUDOROFF 
The Entner-Doudoroff pathway is exclusive to bacteria and archaea.  This pathway is 
required for oxidation of aldonic acids, which are present in the human intestinal tract 
(99).   As in the glycoytic pathway, the Entner-Doudoroff pathway primes glucose by 
phosphorylation ultimately generating glucose-6-phosphate. Glucose-6-phosphate 
dehydrogenase then oxidizes glucose-6-phosphate to 6-phosphogluconate. A subsequent 
dehydration reaction converts 6-phosphogluconate to 2-keto-3-deoxy-6-
phosphogluconate (KDPG).  KDPG is then cleaved by KDPG aldolase (encoded by eda) 
yielding pyruvate and glyceraldehyde-3-phosphate (Fig. 5).  Disruption of the aldolase 
encoded by eda completely inhibits colonization of the mouse intestine by E. coli (127).  
Additionally, the eda mutant is unable to grow in cecal mucus in vitro (127).  These data 
suggest that while in the intestinal lumen, the Entner-Doudoroff pathway is an important 
metabolic pathway.  








When presented with multiple carbon sources, E. coli can either co-metabolize the 
available carbon sources or preferentially use individual carbon sources in a fashion that 
allows for usage of the most accessible and most advantageous metabolite. The most 
classical example of sequential carbon source usage is the glucose-lactose diauxie as 
described by Jacob and Monod (17).  E. coli preferentially uses glucose, and the presence 
of glucose blocks the use of alternative carbon sources in a process known as carbon 
catabolite repression.  In E. coli, carbon catabolite repression is mediated primarily by the 
transcriptional regulator cAMP-CRP (cyclic-AMP bound to cAMP-receptor protein). In 
addition to its primary role catabolic regulation, E. coli cAMP-CRP acts as a global 
regulator that activates over 100 promoters, including several catabolic operons, flagellar 
synthesis and gluconeogenesis (42, 148).  The cAMP-CRP complex also plays an indirect 
role in glycogen metabolism, pH regulation and iron uptake (24).  
 
Carbon catabolite repression is regulated by the phosphorylation state of EIIAGlc, a 
member of the glucose-specific phosphotransferase system (Fig. 6).  When glucose is 
present, phosphoenolpyruvate transiently phosphorylates EIIAGlc, which then 
phosphorylates the EIIBCGlc transporter. Glucose is then phosphorylated as it enters 
through this transporter.  In the absence of active glucose transport, EIIAGlc remains 




Figure 6: The Phosphotransferase System Regulates the Activity of cAMP-CRP.  
 Phosphate is transferred from phosphoenolpyruvate (PEP) via a series of 
phosphotransferase reactions and is ultimately donated to the membrane-bound glucose 
transporter (EIIBCGlc). As glucose is transported into the cell, the phosphate donated by 
EIIBCGlc to the sugar, thereby coupling glucose uptake with its phosphorylation.  In the 
absence of glucose transport, the level of phosphorylated of EIIAGlc increases and is able 
to activate the inner membrane-protein adenylate cyclase (A.C.).  Adenylate cyclase 
converts ATP to cyclic AMP (cAMP).  This small molecule then binds to a dimer of 
CRP, thereby forming the active cAMP-CRP complex. 
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for cAMP production.  Concentrations of glycolytic metabolites also affect A.C. activity.  
Increased proportions of PEP relative to pyruvate leads to increased phosphorylation of 
EIIAGlc, which in turn stimulates A.C. activity.  Intracellular concentrations of cAMP are 
also regulated by synthesis, excretion and degradation of the molecule by cAMP 
phosphodiesterase (114). 
 
Newly synthesized cAMP binds to its regulatory partner CRP.  CRP is a 47-kDa 
protein that functions as a dimer. cAMP binding induces folding of the CRP protein into 
two distinct domains.  The amino-proximal domain is characteristically comprised of 
several beta-sheet motifs, which form the cAMP binding pocket.  The carboxy-proximal 
domain is primarily alpha helical, and acts as the DNA binding surface.  When not bound 
to cAMP, CRP is resistant to proteases, and exhibits sequence independent affinity to 
DNA.  Binding of cAMP enhances CRP affinity for DNA, and subsequently makes DNA 
binding sequence specific.   Although each subunit of CRP can bind one molecule of 
cAMP, stoichiometric and structural studies suggest that the active form of the regulator 
consists of the CRP dimer complexed with one molecule of cAMP (15).  
 
The cAMP-CRP complex activates expression of several catabolic genes and operons 
(15, 42, 102, 150).  Generally, the genes positively regulated by cAMP-CRP are 
characterized by weak promoters.  cAMP-CRP binds upstream of these promoters and 
modifies the promoter such that RNA polymerase promoter recognition is enhanced.  The 
cAMP-CRP binding site is a 22-bp palindromic sequence. cAMP-CRP binding induces a 
structural change near the promoter, and the degree of DNA bending is influenced by 
distal DNA sequences.  DNA bending likely facilitates protein-protein interactions that 
are important for CRP-dependent promoter activation.  CRP binds the RNA polymerase 
holoenzyme in a cAMP-dependent fashion via the RNA polymerase sigma subunit (15) .  
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 In E. coli and S. flexneri, adenylate cyclase is encoded by cyaA.  Expression of 
cyaA is also negatively regulated by cAMP-CRP.  The presence of exogenous cAMP 
represses cyaA expression 9-fold (15).  Furthermore, the cyaA transcript uses a weak 
UUG initiator codon.  However, replacement of the UUG codon with a stronger AUG 
codon did not increase the translational efficiency of cyaA, suggesting that cyaA 
expression is primarily regulated transcriptionally. The cyaA upstream region has three 
promoters, the strongest of which is cyaAP2.  This promoter contains an operator region 
containing a CRP binding consensus.  The current model proposes that cAMP-CRP 
binding to cyaAP2 blocks DNA binding by RNA polymerase.   Expression of crp is 
indirectly inhibited by cAMP-CRP.  Binding of cAMP-CRP to the crp promoter, crpP, 
activates transcription of an antisense RNA from divergent promoter. This antisense 
RNA forms a transcription terminating hairpin loop structure that effectively inhibits 
expression of crp.   
 
In addition to its role in carbon metabolism, cAMP-CRP is also important for both 
cell physiology and virulence.  Mutations in either cyaA and crp lead to abnormalities in 
cell morphology and significant growth defects (25). Expression of the cAMP-CRP 
complex is important for virulence of Yersinia enterocolitica in the mouse model (102).  
Both the crp and cyaA mutants failed to secrete the type III secretion system-dependent 
virulence proteins necessary for virulence, and were unable to spread to the liver and 




In E. coli, Cra (catabolite repressor activator, FruR) is a cAMP-independent regulator 
of central carbon metabolism (113). Cra was originally identified as a repressor of the 
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fructose operon.  However, further studies showed that this 36-kDa protein has additional 
roles in controlling carbon flow and also influences utilization of several exogenous 
carbon sources. Cra is encoded on a monocistronic operon, and the protein has sequence 
homology to the LacI-GalR family of transcriptional regulators (113).  The N-terminal 
helix-turn-helix domain is required for DNA binding whereas the C-terminal ligand-
binding domain is homologous to sugar binding receptors.    
In E. coli and Salmonella enterica serovar Typhimurium  (S. Typhimurium), Cra 
regulates central carbon metabolism (23, 107). Cra upregulates expression of genes 
involved in gluconeogenesis and the Krebs cycle and represses the glycolytic and Entner-
Doudoroff pathways. With respect to catabolite regulation, Cra activates transcription of 
genes subject to catabolite repression while repressing those subject to catabolite 
activation (Fig. 7).  Cra acts as a tetramer (107) and binds to palindromic sequences in the 
operator of regulated genes. The Cra consensus sequence is characterized by an imperfect 
palindrome.  The protein has stronger interactions at the left half of the palindrome as 
compared to the right (91), leading to differing binding affinities. This degeneracy may 
be a result of the multiple roles of Cra and may allow the protein to bind to several 
different DNA sites (107). Of the known Cra regulated genes, only the fru operon 
contains a perfect palindrome.  As expected, Cra binds to this sequence with very high 
affinity and exhibits its highest fold repression, suggesting that Cra originally evolved as 
a fru operon repressor and later acquired pleiotropic roles (107). The effect of Cra on 
transcription is determined by the relative position of the Cra binding site to the RNA 
polymerase binding site (Fig. 7). The glycolytic metabolites fructose-1, 6-bisphosphate 
and fructose-1-phosphate bind to Cra and block its ability to bind to DNA (107).  In this 







Figure 7.   Model of catabolite repression and catabolite activation mediated by the 
transcriptional regulator Cra.    
In the absence of a glycolytic carbon source, Cra binds to operator sequences (O) and 
either activates (gluconeognic genes) or represses (glycolytic genes) transcription by 
affecting binding of RNA polymerase (RPol).  The presence of a glycolytic carbon source 
generates fructose 1,6 bisphosphate or fructose-6-phosphate, and these catabolites (C), 
bind to Cra and change the conformation of this protein thereby preventing Cra from 
binding to its operator sequences. In those genes repressed by Cra, the presence of a 
glycolytic carbon source promotes to transcriptional activation (catabolite activation).  
Conversely, Cra activated genes are repressed by the presence of the glycolytic carbon 
source (catabolite repression). Abbreviations: PTS, phosphotransferase system; -35, -10, 
promoter. Figure adapted from (113). 
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Expression of cra is also required for pathogenesis in S. Typhimurium (2).  When 
administered to mice perorally, a cra mutant of S. Typhimurium was avirulent.  However, 
this strain successfully invaded both M-cells and epithelial cells in vitro and grew as well 
as wild type in mouse mucus in vitro.  Although this strain was immunogenic, it failed to 
persist in the mouse intestine. Similarly, a cra mutation in either commensal or 
pathogenic enterohemorragic E. coli (EHEC) led to significant defects in maintenance 
within the mouse intestine (68). Cra may therefore have an important role in utilization of 
available carbon sources within the mammalian intestine. 
  
7.3 CARBON STORAGE REGULATOR – CSR 
 
In E. coli, CsrA (carbon storage regulator) is a global regulator that post-
transcriptionally controls several diverse processes, including carbon metabolism, 
motility, biofilm formation and cell adherence (6, 72, 109).  CsrA is a primary regulator 
of a larger feedback pathway that includes two non-coding RNAs (ncRNAs), a putative 
inner membrane protein and a two-component system (Fig. 9).  This autoregulatory loop 
allows the cell to fine tune central carbon metabolism and other physiological responses 
to external stimuli.  Homologs of the Csr system have been identified in several gram 
negative bacteria where it functions not only in control of cell physiology, but also 
regulates virulence (Table 1) (72).   
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Table 1: CsrA homologs in bacteria.   
Homologs of E. coli CsrA and its RNA antagonists have been identified in several other 
gram negative bacteria and regulate several distinct steps in pathogenesis. a +, activation; 
-, repression; +/-, mixed response. 
Bacteria CsrA homolog/ 
RNA 
antagonist(s) 
Role (Response)a Reference(s) 
Escherichia coli CsrA/  
CsrB, CsrC 
carbon metabolism (+/-) 
motility (+) 
biofilm formation (-) 
110, 139, 142 
Vibrio cholerae CsrA/  
CsrB, CsrC, 
CsrD 





pathogenesis (+/-) 4 
Pseudomonas aeruginosa RsmA/  
RsmY, RsmZ 
pathogenesis (+/-) 18, 86, 101 
Legionella pneumophila CsrA/  
CsrB, CsrC 
macrophage infection (-) 
intracellular replication (+) 
82 










adherence, invasion (+) 
49 




adherence to epithelial cells (+) 
37 




secretion of translocators (+) 
formation of actin pedestals (+) 






Central to the Csr regulon is a 6.8-kDa protein named CsrA.  CsrA was originally 
identified in E. coli in a screen for mutants that regulated glycogen metabolism (110).  
Disruption of this gene led to a twenty-fold increase in internal glycogen stores (110, 
112). CsrA was later shown to have pleiotropic effects on central carbon metabolism, 
specifically activating glycolysis while repressing both gluconeogenesis and glycogen 
metabolism (112). Like Cra, CsrA regulates metabolism independently of cAMP (110).  
CsrA is thought to regulate the physiological shifts necessary for transition from 
exponential to stationary phase, and accordingly expression of csrA increases two to four 
fold upon entry into stationary phase (43). 
 
 CsrA functions as a homodimeric protein (31, 44). Each subunit is composed of 
five beta strands, a small alpha-helix and a flexible C-terminus (Fig. 8) (44).  The five 
beta strands are intertwined with alpha helices forming a wing-like structure near the C-
terminus.  Although CsrA is not a member of the KH protein family, it contains a 
conserved GXXG RNA-binding motif.  This GXXG motif, located between loops 3 and 





Figure 8: CsrA functions as a post-transcriptional regulator.   
(A) The CsrA dimer is composed of two interdigitated monomers linked via five internal 
β sheets flanked by α helices that form a wing-like structure. The CsrA dimer contains 
two distinct RNA binding sites, composed of the beta-1 strand of one monomer and beta-
5 strand of the second dimer (79).  (B) A mechanism of CsrA mediated repression has 
been described based on the interaction of the protein with the glycogen metabolism 
message glgC (78).  CsrA binds to a high affinity site in the 5’ leader sequence of the 
mRNA, which promotes binding to a second, lower affinity site overlapping the Shine-
Dalgarno (SD) sequence.  By binding to these sites, CsrA blocks ribosome loading and 
decreases translation initation. Modified from Mercante et al.  (78) 
SD AUG 5’ UTR !"!#$










Figure 9.  The CsrA regulatory pathway described in E. coli.   
The post-transcriptional regulator CsrA activates glycolysis while repressing both 
gluconeogenesis and glycogen metabolism.  E. coli CsrA modestly stimulates expression 
of the histidine kinase BarA.  Activation of the BarA-UvrY two component system 
activates expression of the two antagonistic RNAs CsrB and CsrC (highlighted in red).  
Both CsrB and CsrC bind to CsrA and sequester the protein away from its mRNA targets.  
The inner membrane protein CsrD promotes RNase-E mediated degradation of CsrB and 
CsrC.  Modified from Babitzke and Romeo, 1997 (6). 
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With the exception of Hfq mRNA, known CsrA targets contain multiple CsrA 
binding sites.  Despite the variation among these targets, all contain a highly conserved 
GGA motif within stem-loop structures.  To better define the CsrA recognition sequence, 
SELEX (selective evolution of ligands by exponential enrichment) was used to screen a 
combinatorial library of artificially generated, randomized RNAs for CsrA binding.  
Using this method, Dubey et al. (30) defined the CsrA consensus sequence as 
RUACARGGAUGU, where the underlined sequences were highly conserved.  CsrA 
affinity for these sequences was confirmed by gel shift mobility assays.  These studies 
also illustrated a role of both primary and secondary structure in CsrA binding.  Although 
CsrA preferentially binds to GGA motifs within hairpin loops, the stem loop alone is 
neither sufficient nor necessary for binding.  Dubey et al. (30) showed that CsrA does not 
bind arbitrarily to stem loop structures, but that the protein will bind to the consensus 
sequence located in linear RNA.  From these data, a model was proposed in which CsrA 
interacts with the GGA motif within the unpaired loop sequence and partially melts the 
sequence, allowing for further interaction of the protein with the RNA.  This model was 
expanded upon to suggest that disruption of the stem loop would allow the dimeric 
protein to bind to bridge two binding sites via the two functional subdomains on opposite 
sides of the protein (79).  CsrA acts as both an activator and repressor of translation.  As a 
repressor, CsrA binds to sequences that overlap the Shine-Dalgarno sequence and 
competitively inhibits translation initiation by the ribosome (7, 8, 31, 139).  However, the 
mechanism by which CsrA activates translation is not known. It has been postulated that 




  In E. coli, CsrA controls expression of several genes in the central metabolic 
pathways.  Specifically, CsrA represses the glycogen metabolic genes glgCAP and glgB, 
and the gluconeogenic genes pckA and ppsA (112).   Conversely, CsrA activates the 
glycolytic genes pfkA and eno (112).  CsrA does not affect the pentose phosphate 
pathway, and modestly represses the Entner-Doudoroff pathway via an indirect 
mechanism (88, 112).  CsrA has also been shown to regulate metabolism of cyclic di-
GMP (c-di-GMP) by modulating expression of GGDEF proteins involved in synthesis 
and degradation of this second messenger (57).  CsrA may also have a more diverse role 
in cellular processes via its regulation of Hfq.  Hfq is a homohexameric protein that 
pleiotropically regulates cellular function.  This protein promotes small RNA-mRNA 
base pairing necessary for message turnover (81). CsrA binds to a single site in Hfq that 
overlaps the Shine-Dalgarno sequence, thereby competitively inhibiting ribosome 
binding (7). 
 CsrA homologs have been identified in several gram negatives, including enteric 
pathogens, where this protein affects virulence properties, including production of 
cytotoxins, adherence, invasion and survival within the host (4, 9, 13, 18, 37, 49, 70, 82, 
86, 101, 110, 139, 142) (Table 1). Enteropathogenic E. coli (EPEC) is an 
attaching/effacing pathogen that binds to intestinal epithelial cells and is a major 
etiological agent of infantile diarrhea (22). Upon infection, the bacterium binds to host 
cells, inducing massive cytoskeletal rearrangements that result in “pedestal” formation 
around the adhered bacterium. The proteins necessary for pedestal formation are encoded 
on the locus of enterocyte effacement (LEE). LEE consists of several polycistronic 
operons, including LEE 1- 5. In EPEC, CsrA is required for pedestal formation. CsrA 
binds to the leader segment of the LEE mRNA and increases stability of the message 
(13).  Conversely, overexpression of csrA reduces expression of the LEE operons.  
Overexpression of csrA inhibits expression of the LEE activators GlrA and Ler. In 
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addition to virulence regulation, EPEC CsrA also regulates central carbon metabolism, as 
mutation of csrA mutant leads to increased glycogen stores (13).   
S. Typhimurium causes gastroenteritis in humans (71).  This pathogen invades 
intestinal epithelial cells using the chromosomally encoded SPI-1 type III secretion 
system, and effector proteins encoded outside this island.  Expression of SPI-1 was 
significantly decreased in the csrA mutant, and the mutant was subsequently inhibited in 
invasion of epithelial cells in vitro.  Overexpression of csrA also inhibited SPI-1 
expression and invasion, suggesting that CsrA may be both an activator and repressor of 
SPI-1 (4). Unlike in E. coli, S. Typhimurium CsrA does not regulate central carbon 
metabolism.  Instead, S. Typhimurium CsrA appears to have a pivotal role in metabolism 
of maltose, maltodextrins, vitamin B12 and ethanolamine. It has been predicted that S. 
Typhimurium CsrA has adapted to govern utilization of carbon sources used by this 










7.3.2 CsrB and CsrC 
One characteristic feature of the Csr system is two small noncoding RNAs 
(ncRNAs) that control the intracellular levels of CsrA (Fig. 9). In E. coli, the ncRNAs 
CsrB and CsrC have been identified as antagonists of CsrA.  These ncRNAs function as 
CsrA-sinks, and preferentially sequester the protein away from its mRNA targets.  Both 
CsrB and CsrC contain the GGA motif within several stem-loop structures throughout the 
RNA (Fig. 10).  CsrB is the larger of the two RNAs (366 nt) and can bind up to 10 CsrA 
dimers, whereas the 245-nt CsrC RNA binds 5 dimers.  Expression of the ncRNAs is 
independent of the other, but both require CsrA for maximal expression (59, 143). 
Deletion of one of the two ncRNAs leads to a compensatory increase in expression of the 
second RNA (143).  Both CsrB and CsrC have relatively short half-lives (T1/2 = 2 min), 
thereby allowing the cell to respond quickly to stimuli by rapidly modulating the 
availability of CsrA (43, 143). Like csrA, expression of csrB and csrC increases upon 
entry into stationary phase. The response regulator UvrY has been identified as a 
transcriptional regulator of both csrB and csrC (43, 126, 143). However, in the presence 
of glucose, expression of csrC is only partially dependent on UvrY (59).  
 The presence of amino acids has also been shown to affect the expression of csrB 
and csrC (58).  In E. coli, growth in minimal media drastically increased the levels of 
csrB and csrC as compared to growth in LB.  This effect was more pronounced for csrB 
as compared to csrC, which the authors suggest is further evidence for differential 
regulation of the two RNAs.  Additionally, the gluconeogenic carbon sources pyruvate, 
succinate and acetate had a greater effect on RNA expression as compared to glucose.  
Addition of casamino acids to minimal media drastically reduced the level of csrB, 
arguing that the absence of amino acids in minimal media is responsible for induction of 







Output of sir_graph (©)
mfold_util 4.4
Created Mon Feb 15 17:24:27 2010

































































































































































































































G U U G U
C













































































Output of sir_graph (©)
mfold_util 4.4
Created Mon Feb 15 17:30:12 2010









































































































































































































B) CsrC, 245 nt  
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Figure 10: Structure of the antagonistic RNAs CsrB and CsrC from S. flexneri.  
The small, untranslated RNAs CsrB (A) and CsrC (B) bind CsrA and sequester the 
protein away from its normal mRNA targets.  Both RNAs contain several stem loop 
structures and multiple copies of the predicted CsrA binding site.  The S. flexneri csrB 
and csrC sequences are 99% identical to the sequences annotated in E. coli. The 
secondary structure of the RNAs was generated with MFold version 2.3 






Two different groups independently identified CsrD as a regulator of csrB and 
csrC expression in E. coli (59, 125). CsrD functions as a specificity factor that promotes 
RNase-E dependent turnover of both ncRNAs, although CsrD is not a general RNA-
degradation factor (125). In the absence of csrD, the RNA levels and half lives of both 
ncRNAs is increased (125).  This 646 amino acid protein contains a signal sequence, 
transmembrane and coiled coil domains (59).  The inner membrane domain of CsrD is 
not required for activity, but may act in a sensory capacity or may act to subcellularly 
localize the protein. In E. coli, CsrD was predicted to contain both GGDEF and EAL 
domains, which are characteristic of proteins required for cyclic-di-GMP metabolism.  
However, in CsrD these domains do not appear to function in cyclic-di-GMP metabolism 
(125).  Two membrane-spanning regions anchor CsrD in the inner membrane. A HAMP-
like domain, implicated in periplasmic sensing, is also required for CsrD function, 
suggesting that this protein may regulate CsrB and CsrC levels in response to 
extracellular stimuli (125).  
 
7.3.4 BarA-UvrY Two Component System 
 
In E. coli, the BarA-UvrY two-component system also regulates the level of free 
CsrA. Two-component systems are a mechanism by which a bacterium can sense and 
relay signals across the inner membrane.  These systems allow for adaptive response to 
environmental shifts through changes in gene expression. Two-component systems are 
characteristically comprised of two proteins, an inner membrane-bound histidine kinase 
sensor and a cytoplasmic response regulator. The signal is relayed from the sensor kinase 
to the response regulator by a series of phosphorylation/dephosphorylation reactions.  In 
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response to stimuli, the sensor kinase autophosphorylates on a conserved histidine 
residue. The phosphate is then transferred to the response regulator, thereby causing a 
conformational change in the response regulator that allows it to bind promoters of target 
genes and regulate gene expression (52).   
 
BarA was originally identified because of its ability to phosphorylate the osmotic 
response regulator OmpR (55).  Because of its ability to rescue osmotic regulation, this 
protein was named the bacterial adaptive response protein A.  The BarA histidine kinase 
belongs to a unique group of tripartite sensors containing phosphoryl transfer, receiver 
and histidine phosphotransfer output domains.  Tripartite histidine kinases catalyze the 
phosphorylation of cognate response regulators via an ATPHisAspHisAsp 
phosphorelay.  Likewise, dephosphorylation of the activated response regulator occurs 
via a reverse AspHisAspPi reaction.  The periplasmic sensor domain of BarA and 
its homologs are poorly conserved, implying that these kinases lack a common signal 
(47).  
 
The response regulator UvrY was so named for its bicistronic linkage to the UV-
induced repair gene uvrC.  Despite this proximity, UvrY has no documented effect on 
UV-induced DNA repair (100).  In laboratory strains of E. coli, the BarA-UvrY system 
regulates the level of free CsrA by activating expression of both CsrB and CsrC (126, 
143). Phosphorylation of UvrY by BarA activates the response regulator, which in turn 
upregulates expression of csrB and csrC. In E. coli, CsrA has also been shown to 
modestly increase expression of BarA (126), enabling further regulation of the system. 
The signal to which BarA responds is still unknown, although it has been hypothesized 
that BarA may respond to an intracellular indicator of carbon availability (126).  No other 




8. Purpose of this Research 
To successfully establish infection, S. flexneri must adapt to the unique 
microenvironments encountered in the host.  The bacterium likely encounters different 
carbon sources throughout infection, as it travels from the external to internal milieu, and 
as it competes for resources in the host lumen and utilizes available nutrients in the host 
cytosol.  The adaptation to these environments likely relies on one or more the above-
mentioned regulators to coordinate metabolic gene expression with the available 
resources.  These regulators may also have a secondary role in coordinating cell 
physiology and virulence factors with the environment.  The purpose of this research is to 
examine the role of cAMP-CRP, Cra and CsrA in S. flexneri pathogenesis, specifically 
examining how these regulators affect the process of invasion and intercellular survival.  
By examining the metabolic strategies of S. flexneri, these studies provide a better 
understanding of the mechanisms by which this cytosolic pathogen has adapted to an 
intracellular lifestyle.  Such knowledge may aid in future work to prevent Shigella 
infection, specifically in the development of probiotic therapies that may block initial 
colonization by the bacterium. 
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II. MATERIALS AND METHODS 
 
1. Bacterial strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Tables 2 and 3, 
respectively.  The E. coli strain DH5α was used for cloning of recombinant DNA.  The 
E. coli strains TRMG1655 (110), TWMG1655 (143) and RG1-B (43) were kindly 
donated by Dr. Tony Romeo, University of Florida, Gainesville. Keio mutants were 
provided by the E. coli Genome Analysis Project (5). The S. flexneri strain 2457T, a 
serotype 2a wild type strain, was used to generate all mutants.  SA101 is a spontaneous 
avirulent 2a strain, and was used as a negative control where noted (28).  
2. Media, Reagents and Growth conditions 
All strain stocks were maintained at -80°C in tryptic soy broth (TSB) supplemented 
with 20 % v/v glycerol.  E. coli strains were grown in Luria-Bertani (LB) broth (1% 
tryptone, 0.5% yeast extract, 1% sodium chloride) or on LB agar plates.  S. flexneri 
strains were grown in LB broth or on TSB agar plates containing 0.01% Congo red dye 
(TSBA-CR).  Where noted, the minimal media M63, modified M9 (MM9) or T-medium 
were used.  MM9 contained 30 mg/L monobasic potassium phosphate, 50 mg/L sodium 
chloride, 100 mg/L ammonium chloride, 6 g/L sodium hydroxide and 30 g/L PIPES. 
MM9 media was supplemented with 1 mM magnesium sulfate, 100µM calcium chloride, 
2 µg/ml nicotinic acid, 20 µg/ml tryptophan and 2 µg/ml thiamine.  M63 contained 13.6 
g/l monobasic potassium phosphate, 2 g/L ammonium sulfate, 0.5 mg/L ferrous sulfate, 
and was supplemented with 1 mM magnesium sulfate, 100µM calcium chloride, 2 µg/ml 
nicotinic acid, 20 µg/ml tryptophan and 2 µg/ml thiamine, 5µg/ml 2-deoxyadenosine and 




Table 2: Strains Used in this Study 
Strain Relevant Characteristics Source or Reference 
E. coli   
 DH5α endAI, hsdR17, supE44, thi-1, recA1, 
gyrA, relA1, Δ(lacZYA-argF), U169, 
deoR, [φ80dlacΔ(lacZ)M15] 
Sambrook and Russell, 
2001  (116) 
 JW1899 BW25113 uvrY::km Keio collection (5)  
 JW5702-2 BW25113 crp::km Keio collection  
 JW2757 BW25113 barA::km Keio collection  
 JW3778 BW25113 cyaA::km Keio collection  
 JW3221 BW25113 yhdA::km Keio collection  
 JW0078 BW25113 cra::km Keio collection  
 JW1692 BW25113 ppsA::km Keio collection  
 JW3393 BW25113 glgC::km Keio collection  
 RG1-B MG1655 csrB::cm T. Romeo 
 TRMG1655 MG1655 csrA::km T. Romeo 
 TWMG1655 MG1655 csrC::km T. Romeo 
S. flexneri 
 2457T Shigella flexneri 2a, wild type  
 SA101 S. flexneri 2a SA100 spontaneous Crb- Daskaleros and Payne, 1987 
(28) 
 SA555-148 S. flexneri 2a SA100, rfaX::TnphoA Hong and Payne, 1997  (54) 
 AGS100 2457T barA::km this study 
 AGS110 2457T uvrY::km this study 
 AGS120 2457T csrA::km this study 
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 AGS130 2457T csrB::cm this study 
 AGS140 2457T csrC::tet this study 
 AGS150 2457T csrD::km this study 
 AGS160 2457T csrB::cm, csrC::tet this study 
 AGS170 2457T crp::km this study 
 AGS180 2457T cyaA::km this study 
 AGS190 2457T cra::km this study 
 AGS200 2457T ppsA::km this study 
 AGS210 2457T glgC::km this study 




Table 3: Plasmids Used in this Study 
 
 
Plasmid Characteristics Source or Reference 
Cloning Vectors 
pGEM-T Easy PCR cloning vector Promega 
pQE2 IPTG-inducible gene expression vector Qiagen 
pWSK29 Low-copy number expression vector Wang and Kushner, 1991 
(138) 
pWKS30 Low-copy number expression vector Wang and Kushner, 1991 
Gene Expression 
pWCrp pWKS30 with crp promoter and coding region this study 
pWCyaA pWKS30 with cyaA promoter and coding 
region 
this study 
pQCsrA pQE2 with csrA under control of IPTG 
inducible promoter 
this study 
pQCsrB pQE2 with csrB under control of IPTG 
inducible promoter 
this study 
pQCsrC pQE2 with csrC under control of IPTG 
inducible promoter 
this study 
pWCsrA pWSK29 with csrA promter and coding region this study 
pWCra pWKS30 with cra promoter and coding region this study 
pWPfkA pWSK29 with pfkA promoter and coding region this study 
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T-medium was prepared as described in Simon and Tessman, 1963 (121),  and was 
routinely supplemented with 0.4% carbon source and 2 µg/ml nicotinic acid.   EZ rich 
defined media (EZ-RDM, www.genome.wisc.edu/resources/protocols/ezmedium.html) 
was also used, and is a modification of the supplemented MOPS minimal media 
described by Neiderhardt et al.  (92).  Unless otherwise noted, carbon sources were added 
to EZ-RDM at a final concentration of 0.2% (w/v).   
Antibiotics were added at the following concentrations per milliliter:  25µg ampicillin 
(Amp), 30µg chloramphenicol (Cm), 1.6µg tetracycline (Tet), and 50µg kanamycin 
(Km).  Gene expression was induced by adding isopropyl beta-d-1-thiogalactopyranoside 
(IPTG) where noted.   
3. P1 vir transduction to generate mutants 
S. flexneri mutants AGS100 - 220 were generated by bacteriophage P1 vir 
transduction from the E. coli strains listed in Table 2, following a modification of the 
protocol described in Sambrook (116).  Bacteriophage stocks were routinely amplified on 
the E. coli strain MG1655 on T-medium agar containing 10 mM calcium chloride and 1 
mM dithiothreitol (DTT).   Mutant strains were selected by plating recipient cells on 
TSBA-CR with 2.5 mM sodium citrate with the appropriate antibiotic marker. For those 
mutants marked with a kanamycin resistance cassette, 200µg/ml kanamycin was added to 
TSBA-CR selection plates.  All mutants were confirmed by polymerase chain reaction 
(PCR) with primers internal to the antibiotic cassette and flanking the mutated gene.  
4. Oligonucleotides and Polymerase Chain Reaction  
Oligonucleotides used in this study are listed in Table 4.  Primers were designed 
using Clone Manager software (Sci-Ed Software, Cary, NC), and purchased from Sigma 
(St. Louis, MO), Invitrogen (Carlsbad, CA) or Integrated DNA Technologies (Coralville, 
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IA). Lyophilized oligonucleotides were resuspended in sterile Milli-Q (Millipore, 























Table 4: Oligonucleotide primers used in this study 
Primer Sequence (5’ – 3’) 
CRP WKS fwd GAATCCAAATCGCGCAACGGAAGG 
CRP WKS rev GAGCTCCAGCGTTTGTCGAAGTGCATAG 
pWCyaA fwd GAATTCGTGCTACACTTGTATGTAGCG 
pWCyaA rev GAGCTCGATTGCATGCCCGGATAAGCC 
csrA fwd BseRI ATCTGAGGAGCAGCAAAGTATGCTGATTCTG 
csrA rev HindIII AAGCTTGGGTGCGTCTCACCGATAAAG 
pQCsrB fwd GAATTCATCTTCGTCGACAGG 
pQCsrB rev AAGCTTAAAACTGCCGCGAAGGATAGC 
pQCsrC fwd GAATTCCAAAGGCGTAAAGTAGCACCC 
pQCsrC rev AAGCTTCTTTTGCATGACCTTTGCTGCG 
pWCra fwd GAATTCTGCGAAATCAGTGGGAAC 
pWCra rev GCGGCCGCGTTGGCAGCATTACCTTG 
pCC-CsrA fwd GAATTCACTCGCTTCACGGCATTC 
pCC-CsrA rev AAGCTTAACGGAGGTCTGGCAGATAG 
pWPfkA fwd GTGGACAGGGAGGGTAAACGGTCTATG 
pWPfkA rev GCGGCCGCCTTGCGGGTATATGTTGAGGG 
  
Real Time Primers  
virB2 for 5’ TCCAATCGCGTCAGAACTTAACT 3’ 
virB2 rev 5’ CCTTTAATATTGGTAGTGTAGAACTAAGAGATTC 3’ 
virB2 probe 5’ FAM –AGGACTTGAAAAGGC-MGBNFQ 3’ 
virF for 5’ TCGATAGCTTCTTCTCTTAGTTTTTCTG 3’ 
virF rev 5’ GAAAGACGCCATCTCTTCTCGAT 3’ 
virF probe 5’ FAM-TCAGATAAGGAAGATTGTTGAAA-MGBNFQ 3’ 
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PCR for routine screening were performed using Taq polymerase (Qiagen or New 
England Biolabs) per the manufacturers instructions.  Each 100µl PCR reaction contained 
100µM each dNTP, template DNA, 10µM each primer in Taq polymerase buffer.  For 
the Taq polymerase PCR reactions, the cycling conditions are as follows: 5 minute 
denaturation at 94°C, followed by 30 cycles of 30 seconds at 94°C, 50°C annealing for 30 
seconds and extension at 72°C for 1 minute per 1000 bp DNA.  Taq PCRs were 
completed by a final extension at 72°C for 15 minutes.  Taq plus Pfu (Stratagene, La 
Jolla, CA) or Platinum Pfx polymerase (Invitrogen) was used for generating DNA 
fragments for gene expression.  Taq plus Pfu PCR reactions were performed as described 
for Taq reactions.  Each Pfx reaction (50µl) contained 300µM of each dNTP, 0.3µM of 
each primer, and template DNA in Pfx PCR buffer.  Three step cycling was used for all 
Pfx amplifcations as follows: 2 minute denaturation at 94°C, followed by 30 cycles for 
denaturation at 94°C for 15 seconds, annealing at 55°C for 30 seconds and extension at 
68°C for 1 minute per kilobase of DNA.  The Pfx PCR reaction was terminated by 
incubating the product at 4°C.  
5. DNA Sequencing 
Cloned DNA fragments and PCR products were confirmed by sequencing. 
Sequencing was performed at the University of Texas at Austin DNA sequencing facility 
using an ABI 3130 sequencer  (Applied Biosystems, Foster City, CA) and automated dye 
termination procedure.  All sequences were analyzed using Clone Manager Professional 
software. 
6. DNA Isolation 
Plasmid DNA was isolated from cells using the Sigma (St. Louis, MO) GenElute 
plasmid prep kit following the manufacturers instructions.  DNA fragments were isolated 
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from agarose gels using the Sigma GenElute gel extraction kit per the manufacturer’s 
instructions.  Isolated DNA was eluted with either the provided elution buffer or H2O and 
stored at -20°C. 
7. Restriction Digests and Ligation 
All restriction digests and were performed per the manufacturers directions.  
Restriction enzymes and DNA size markers were purchased from New England Biolabs. 
DNA size was estimated using the φX DNA-HaeIII and λ DNA-HindIII digests.  
Ligations were performed by incubating DNA fragments with T4 DNA ligase (Fisher 
Scientific, Pittsburgh, PA), according to the manufacturer’s directions and transformed 
into the appropriate strain. 
8. Transformation of Bacterial Strains 
8.1 TRANSFORMATION OF E. COLI BY HEAT SHOCK 
Ligation products or plasmid DNA was introduced into CaCl2 competent E. coli strain 
DH5α by heat shock transformation.  DH5α was made heat-shock competent by 
subculturing an overnight culture of DH5α 1:100 into LB broth and growing the culture 
at 37°C until midlog phase.  Bacteria were collected by centrifugation at 3000 x g for 10 
minutes, and the supernatant was decanted.  The bacterial pellet was resuspended in 10 
ml ice-cold CaCl2 solution (10 mM PIPES, 60 mM CaCl2, 15% glycerol).  The 
centrifugation and resuspension steps were repeated twice, and after the third 
centrifugation, the bacteria were resuspended in 2 ml cold CaCl2 solution.  Aliquots of 
150µl of resuspended bacteria were stored at -80°C.  To transform bacteria, plasmid 
DNA (100 - 200ng) or ligation mixture was added to CaCl2 competent bacteria and 
incubated on ice for up to two hours.  The bacteria were then heat shocked at 42°C for 2 
minutes, followed by a 2-minute incubation on ice.  The bacteria were inoculated into 
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850µl LB broth.  After a 1-hour incubation at 37°C with aeration, transformed bacteria 
were isolated by plating the culture on LB agar with the appropriate antibiotics. 
8.2 ELECTROPORATION OF S. FLEXNERI 
To make electrocompetent S. flexneri, overnight cultures were subcultured 1:100 into 
fresh LB broth with appropriate antibiotics, and grown to midlog phase at 37°C with 
aeration.  Bacteria were harvested by centrifugation at 6000 x g in pre-chilled rotor.  The 
bacterial pellet was then resuspended in 20 ml G-buffer (137 mM sucrose, 1 mM HEPES, 
pH 8.0).  The pelleting and resuspension steps were repeated twice, and after the third 
centrifugation, the bacteria were resuspended in 400µl G-buffer.  One hundred microliter 
aliquots of the cell suspension were stored at -80°C.  
 To transform S. flexneri, 5µl of plasmid DNA and 1.7µl of 20% sucrose were 
added to 100µl of electrocompetent bacteria.  S. flexneri was electroporated in a 
GenePulse electroporator (BioRad, Hercules, CA) using the following settings: 200 Ω,  
25 mF, 24V.  Bacteria were then inoculated into 800µl of LB broth and incubated at 37°C 
with aeration for an hour.  Transformed bacteria were selected by plating the culture on 
TSBA-CR with the appropriate antibiotic. 
9. Construction of plasmids 
9.1 PWCRP 
The crp mutation in S. flexneri strain AGS170 was complemented by expressing the 
wild type crp gene from its native promoter in the low copy vector pWKS30.  Wild type 
crp was amplified by PCR from 2457T using primers CRP WKS fwd and CRP WKS rev.  
The PCR-amplified DNA fragment was digested with EcoRI and NotI, and ligated into 




The plasmid pWCyaA was used to complement the cyaA mutation in S. flexneri strain 
AGS180.   To construct this plasmid, wild type cyaA was amplified from 2457T by PCR 
using the primers pWCyaA fwd and pWCyaA rev.  The resulting PCR fragment was then 
ligated into pGEMt-Easy, creating pGWCyaA.  The cyaA gene was then excised from 
pGWCyaA by digestion with EcoRI and NotI and ligated into similarly cut pWKS30 
(138) to create pWCyaA. 
9.3 PQCSRA 
Overexpression of csrA was achieved by cloning the csrA gene under the control of 
an IPTG inducible promoter in the expression plasmid pQE2 (Qiagen).  The csrA gene 
from S. flexneri 2457T was amplified by PCR using the forward primer csrA fwd BseRI 
and reverse primer csrA rev HindIII.  The amplified DNA fragment was digested with 
BseRI and HindIII and cloned under the control of the T5 IPTG-inducible promoter in 
similarly digested pQE2.  The resulting plasmid, pQCsrA, was also confirmed by 
sequencing. 
9.4 PQCSRB AND PQCSRC 
The csrB and csrC overexpression vectors, pQCsrB and pQCsrC respectively, were 
created by amplifying csrB and csrC from 2457T by PCR.  Primers pCsrB fwd and 
pCsrB rev were used to amplify csrB, and csrC was amplified using the primers pQCsrC 
fwd and pQCsrC rev.  The resulting DNA fragments were cloned into pGEMt-Easy to 
create the plasmids pGQCsrB and pGQCsrC.  The csrB and csrC fragments, from 
pGQCsrB and pQCsrC respectively, were excised using HindIII and EcoRI, and ligated 
into similarly digested pQE2 to generate pQCsrB and pQCsrC. In these plasmids, both 
genes are under the T5 IPTG-inducible promoter in pQE2. The resulting plasmids were 




To complement the S. flexneri csrA mutant AGS120, csrA from wild type S. flexneri 
was cloned in the low copy vector pWSK29 under the control of its native promoter.  
Using genomic DNA from 2457T as template, csrA was amplified using the primers 
pCC-CsrA fwd and pCC-CsrA rev by PCR.  The PCR product was ligated into pGEM-T 
Easy (Promega) thereby generating the plasmid pGWCsrA.  The csrA fragment was 
excised from pGWCsrA by digestion with SacII and HincII and ligated into similarly 
digested pWSK29 (138).  The resulting plasmid, pWCsrA was confirmed by sequencing.   
9.6 PWCRA 
For complementation of the cra mutant AGS190, cra was amplified from 2457T 
using the primers pWCra fwd and pWCra rev. The resulting PCR product was cloned 
into the T-overhangs of pGEM-T Easy, yielding the plasmid pGWCra.  Both pWKS30 
and pGWCra were digested with EcoRI and NotI, and the digested plasmid and cra insert 
were ligated to create pWCra.  The cloned cra fragment was confirmed by sequencing. 
9.7 PWPFKA 
The pfkA mutant, AGS220, was complemented by PCR amplifying wild type S. 
flexneri pfkA using primers pWPfkA-fwd and pWPfkA-rev.  The resulting pfkA DNA 
fragment, which contains pfkA under the control of its native promoter, was ligated into 
pGEM-T Easy, yielding pGWPfkA.  The pfkA gene in pGWpfkA was excised by 
digestion with SalI and NotI.  The complementing plasmid pWPfkA was generated by 
ligating the into the low copy vector pWSK29, also digested with SalI and NotI.  The 
cloned pfkA gene was confirmed by sequencing. 
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10.  Cell Culture  
Henle cells (intestinal 407, American Type Culture Collection) were cultured in 
minimal essential media (MEM, Gibco) supplemented with 10% bacto-trytone phosphate 
broth (Difco, Becton-Dickinson Company, Franklin Lakes, NJ), 10% fetal bovine serum 
(Gibco), 2 mM glutamine and 1X nonessential amino acids (Gibco).  Henle cells were 
routinely incubated at 37°C with 95% air – 5% CO2. 
11.  Cell Culture Assays 
11.1 INVASION ASSAYS 
Invasion assays were performed essentially as described by Hong and Payne (54).  
Several red colonies from an overnight TSBA-CR plate were used to inoculate LB broth 
and the cultures were grown at 37°C with aeration to exponential phase. When necessary, 
the appropriate antibiotic was included in the growth media.  Approximately 2x108 cells 
were added to a subconfluent monolayer of Henle cells in 35 mm 6-well polystyrene 
plates (Corning) and centrifuged for 10 minutes at 700 x g in a Centra GP8 centrifuge 
(International Equipment Company, Needham Heights, MA).  After centrifugation, the 
monolayers were incubated for 30 minutes at 37°C with 5% CO2.  To remove extracellular 
bacteria, the monolayers were washed with phosphate buffered saline (1X PBS-D: 1.98 g/L 
potassium chloride, 8 g/L sodium chloride, 0.02 g/L monobasic potassium phosphate, 1.4 g/L 
dibasic potassium phosphate, pH 7.5).  Monolayers were then overlaid with two milliliters 
MEM supplemented with 20µg/ml gentamycin per well.  Plates were incubated an additional 
40 minutes, washed with 1X PBS-D, then stained with Wright-Giemsa stain (Camco, Ft. 
Lauderdale, FL), washed with distilled water and air dried.   Internalized bacteria were 
visualized by microscopy at 600X magnification.  Henle cells containing 3 or more internal 
bacteria were scored positive for invasion, and at least 300 Henle cells were examined per 
well.   
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 In the complement invasion assays involving pQCsrA, cells were grown to mid-
logarithmic phase (A650 = 0.5), at which point IPTG was added at a final concentration of 
150µM.  Cultures were then grown to exponential phase, and the invasion assay was 
performed with an additional 150µM IPTG added to the culture media throughout the 
duration of the assay.  For the pQCsrA overexpression invasion assays, cultures were grown 
to exponential phase, and 200µM IPTG was added for 30 minutes to induce expression of 
csrA.  Cells were similarly grown for the pQCsrB and pQCsrC invasion assays, except that 
200µM IPTG was added for 15 minutes to induce expression of the RNAs.  200µM IPTG 
was added to the culture media where for the duration of the assay. 
To test the role of gluconeogenic carbon sources in the invasion of the pfkA mutant, 
several red colonies were used to inoculate an overnight culture in MOPS-minimal media 
with 0.2% pyruvate as a carbon source.  The overnight culture was then subcultured to a 
starting A650 of 0.02 into fresh MOPS medium supplemented with 0.2% carbon source.   
Cultures were then incubated at 37°C with aeration until exponential phase, and the standard 
invasion assay protocol was followed. 
11.2 ATTACHMENT ASSAYS 
To measure adherence of the bacteria to epithelial cells, S. flexneri strains were grown 
to midlog phase in LB broth, and approximately 2x108 bacteria were added to a 
subconfluent monolayer of epithelial cells in 35 mm 6-well plates.  Plates were 
centrifuged for 5 minutes at 700 x g in a Centra GP8 centrifuge, then incubated for 15 
minutes at 37°C in 5% CO2 prior to staining as described as above.  Adherent bacteria 
were counted by microscopy at 600X magnification.  One hundred Henle cells were 
examined in each experiment, and the total number of bacteria present per cell was 
recorded for each strain. 
60 
 
11.3 PLAQUE ASSAYS 
The plaque assay was performed as previously described (45, 54).  Approximately 
105 exponential phase bacteria grown in LB broth were added to confluent monolayers of 
Henle cells cultured in 6 well polystyrene plates.  Bacteria were centrifuged on to 
monolayers for 10 minutes at 700 x g in a Centra GP8 centrifuge, and then incubated for 
45 minutes in a 5% CO2 atmosphere at 37°C.  Monolayers were then washed with 1X 
PBS-D, then overlayed with MEM containing 0.3% glucose and 40 µg/ml gentamycin. 
The gentamycin selectively kills any extracellular bacteria, ensuring that any plaques 
formed are the result of intracellular spread by S. flexneri. After 48 hours incubation, 
wells were washed with 1X PBS-D and stained with Wright-Giemsa. Plaques are scored 
for size and clarity, as these features correlate with efficiency of Shigella to grow within 
the eukaryotic cytosol and propagate to adjacent cells. 
11.4 RECOVERY OF EXTRACELLULAR AND INTRACELLULAR S. FLEXNERI 
Bacteria were grown as described in the invasion assay, and 5x109 cells were added to 
a confluent monolayer of Henle cells grown in a 96 cm2 Roboflask (Corning).  Bacteria 
were centrifuged onto the monolayer in a Centra GP8 centrifuge for 10 minutes at 700 x 
g, then incubated for 30 minutes in a 5% CO2 atmosphere at 37°C.  After the initial 
incubation, the media was removed by pipetting and noninvaded (extracellular) bacteria 
were collected by centrifugation for 7 minutes at 6000 x g in a Sorvall rotor.  The 
extracellular bacterial pellets were then resupsended in 100µl 1X PBS-D. Monolayers 
were then washed with PBS-D, overlayed with MEM supplemented with 80µg 
gentamycin, and incubated an additional 2 hours at 37°C with 5% CO2.  Monolayers were 
washed again with PBS-D, and intracellular bacteria were released by lysing Henle cells 
with 2.5% w/v saponin for 8 minutes at 37°C.  The cell lysate was recovered by 
centrifugation at 6000 x g for 7 minutes in a Sorvall SS34 rapid access rotor (Thermo-
Fisher Scientific, Rockford, IL).  Cell pellets were washed with 1X PBS-D and 
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centrifuged twice, and after the final spin, the recovered bacteria were resuspended in 
200µl 1X PBS-D.   
12. Real Time PCR 
Colonies grown overnight on TSBA-CR plates were used to inoculate LB broth, and 
strains were grown to exponential phase at 37°C with aeration.  Approximately 8x108 
cells were used for isolation. RNA was isolated using the Qiagen RNeasy mini prep kit.  
After elution, RNA was treated with 10 units of DNase (Invitrogen) and precipitated 
overnight. Samples were then washed with ethanol, then resuspended in 40µl DEPC-
treated H2O.  RNA was quantified using an ND-1000 spectrophotometer (NanoDrop, 
Wilmington, DE).  Approximately 2µg RNA was used to make cDNA using the High 
Capacity cDNA Reverse Transcription kit (Applied Biosystems) per the manufacturer’s 
directions.  cDNA was then diluted 1:10 in DEPC-treated H2O, and 2.5 µl of this dilution 
was used as template for real-time PCR.  The reaction was performed using minor groove 
binding (MGB) primers and FAM-labeled probes previously described by Murphy and 
Payne (87) using Primer Express.  The real time reaction was performed using a 7300 
real time PCR system (Applied Biosystems) under standard conditions.  Samples were 
normalized to the dksA control, and calibrated to the wild type strain 2457T.   
13. Protein Analysis 
13.1 ISOLATION AND DETECTION OF WHOLE CELL PROTEINS 
Several colonies grown on TSBA-CR plates were used to inoculate LB broth and 
cultures were grown to exponential phase at 37°C with aeration.  Cultures were 
centrifuged to collect bacteria, and approximately 109 cells were resuspended in 100µl 1X 
PBS-D and 100µl 2X sample buffer (0.001% v/v β-mercaptoethanol, 2% w/v SDS, 10% 
v/v glycerol, 5% bromophenol blue, 63 mM Tris-Cl).  Samples were lysed by boiling for 
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10 minutes, and 10µl of cell lysate was resolved on a 12% sodium dodecyl sulfate 
polyacrylamide gel (SDS-PAGE), then visualized by Coomassie staining. 
13.2 ISOLATION AND DETECTION OF SECRETED PROTEINS 
Secreted proteins were examined using a modification of the protocol described 
by Murphy and Payne (87). Approximately 109 bacteria from cultures grown to 
exponential phase in LB broth were centrifuged and resuspended in 100µl 1X PBS-D.  
Congo red was added at a final concentration of 0.005% to cell suspensions, and the 
suspensions were incubated at 37°C for 20 minutes without aeration.  Bacteria were 
removed by centrifugation for 10 minutes at 16,300 x g.  To precipitate the secreted 
proteins, 10 µl of 100% trichloroacetic acid was added to 100µl of the resulting 
supernatant.  Secreted proteins were precipitated overnight at 4°C, and collected by 
centrifugation for 15 minutes at 16,300 xg at 4°C.  Protein pellets were washed with 
100% cold acetone and dried.  The precipitated proteins were resuspended in 25µl 1X 
PBS-D and 25µl 2X sample buffer, and 10µl of sample was electrophoresed on a 12% 
SDS-PAGE gel, then visualized by silver staining as described by Morrissey, 1981 (84).  
Protein size was estimated using precision plus dual color protein marker (BioRad) for all 
SDS-PAGE gels.  
13.3 PREPARATION OF PROTEINS FROM INTRACELLULAR BACTERIA 
One hundred microliters of 2X SDS-PAGE buffer was added to 100µl of 
recovered extracellular or intracellular bacteria. Samples were boiled for 10 minutes, and 
10 µl of sample was loaded onto a 12% SDS-PAGE gel.  Proteins recovered from 
extracellular bacteria were diluted 1:10 in 1X PBS-D prior to loading. After 
electrophoresis, proteins were visualized by silver staining, following the protocol of 
Morissey, 1981 (84). 
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13.4 IMMUNOBLOTTING OF IPA PROTEIN SAMPLES 
After electrophoresis, proteins were transferred to a 0.45µm pore-size nitrocellulose 
membrane (Hybond-ECL, GE).  Blots were probed with monoclonal anti-IpaB or 
monoclonal anti-IpaC antibodies (E. V. Oaks, WRAIR), followed by goat anti-mouse 
HRP conjugated secondary antibody (BioRad).  Signal was detected by developing the 
blot with the Pierce ECL-detection kit (Thermo-Fisher Scientific) 
14. IcsA localization 
Approximately 109 bacteria from cultures grown to exponential phase in LB broth 
were used to examine IcsA localization.  Bacteria were fixed in 4% paraformaldehyde for 
15 minutes at 25°C, and then washed with 1X PBS-D.  Bacteria were incubated for 1 
hour at 25°C with 1:100 dilution of rabbit anti-IcsA antibody made in PBS-D.  After 
washing in PBS-D, bacteria were labeled in the dark with 100µl of FITC anti-rabbit 
antibody for an additional hour at 25°C.  Unbound FITC was removed by washing the 
bacteria with PBS-D, and labeled bacteria were spread on a glass microscope slide.  Slow 
Fade Gold (Invitrogen) was added to prevent photobleaching.  IcsA localization was 
observed under a light microscope using a FITC-filter, and images were captured with 
SpotAdvance software (Diagnostic Instruments, Sterling Heights, MI). 
15. Analysis of Lipopolysaccharide 
15.1 PREPARATION OF LIPOPOLYSACCHARIDE SAMPLES 
Lipopolysaccharide extraction was performed essentially as described by 
Hitchcock and Brown (51).  Strains were grown to midlog phase in LB broth, and 109 
bacteria were harvested by centrifugation.  Bacterial pellets were resuspended in 50µl 
LPS lysis buffer (2% w/v SDS, 4% v/v 2-mercaptoethanol, 10% v/v glycerol, 1M Tris-Cl 
(pH 6.8), 0.05% bromophenol blue), and boiled for 10 minutes and cooled on ice. 
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Twenty-five micrograms of proteinase K (Sigma-Aldrich) was added to samples, and 
then samples were incubated for 1 hour at 65°C.  LPS samples were then boiled an 
additional 5 minutes, then 2.5 - 5µl was loaded on a 12% tricine SDS-PAGE gel.   
15.2 ISOLATION OF LIPOPOLYSACCHARIDE FROM INTRACELLULAR 
BACTERIA 
Bacteria recovered from the extracellular or intracellular environment were 
collected by centrifugation and resuspended in 100µl of LPS lysis buffer.  Samples were 
boiled for 10 minutes then cooled on ice. One milligram of proteinase K was added and 
samples were incubated at 60°C for 1 hour.  LPS samples were boiled an additional 5 
minutes, and 5µl of sample was loaded onto a 12% tricine SDS-PAGE gel.  Extracellular 
samples were diluted 1:20 in LPS lysis buffer before loading. 
 
15.3 SILVER STAINING OF LIPOPOLYSACCHARIDE SAMPLES 
Silver staining of LPS samples was performed as described by Tsai and Frasch 
(133).  After electrophoresis, gels were fixed in isopropanol fixative (40% isopropanol, 
5% glacial acetic acid) for 1 hour or up to overnight. After fixation, gels were soaked in 
0.7% periodic acid (made in isopropanol fixative), for 15 minutes, then washed three 
times in Milli-Q purified H2O.  Gels were then soaked for 10 minutes in 20% silver 
nitrate, and washed three times with Milli-Q purified H2O.  After washing, LPS was 
visualized by soaking gels in developing solution (0.0185% v/v formaldehyde, 50µg/ml 
citric acid).  Development was stopped by washing gels repeatedly in Milli-Q purified 
H2O.   
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15.4 IMMUNOBLOTTING OF LIPOPOLYSACCHARIDE SAMPLES 
After electrophoresis, LPS samples were transferred from the gel to a 0.2µM pore-
sized nitrocellulose membrane (GE) at 100 mA for 2 hours.  To visualize total LPS, 
membranes were probed with rabbit group B antisera (Difco) for 2 hours, followed by a 
one-hour incubation with goat anti rabbit HRP conjugated secondary antibody (BioRad). 
S. flexneri LPS core was detected by probing membranes with the mouse antibody 
MASF-2a (19) for 18 hours, followed by a 90 minute incubation with goat anti-mouse 
HRP conjugated secondary antibody (BioRad). Signal was detected using the Pierce ECL 
detection kit (Thermo-Forma Scientific).   
16. Glycogen staining 
Glycogen staining was performed as described in Romeo et al.  (110).  Strains were 
streaked onto Kornberg agar (1.1% dibasic potassium phosphate, 0.85% monobasic 
potassium phosphate, 0.6% yeast extract) supplemented with 1% glucose, and incubated 
overnight at 37°C.  Plates were then inverted over iodine crystals for 15-30 seconds to 
stain internal glycogen with iodine vapor. 
17. BioLog phenotype microarrays 
To examine differences in carbon source utilization, BioLog phenotype microarrays 
(BioLog, Hayward, CA) were performed.  Colonies were harvested from TSB agar plates 
without Congo red and resuspended in 1 ml saline, then diluted to a final concentration of 
109 cfu per ml in saline.  The cell suspension was next diluted to 107 cfu per ml in 
inoculating fluid (BioLog) supplemented with 2µg/ml nicotinic acid.  Each well of the 
phenotype microarrays was inoculated with 106 cfu and incubated at 37°C for 24 hours.  
The absorbance at wavelength of 595 was recorded every 2 hours using an Opsys MR 
plate reader (Dynex, Chantilly, VA).  
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18.  Detergent sensitivity 
Bacteria were inoculated into LB broth and grown to exponential phase at 37°C with 
aeration.  The equivalent of an absorbance unit at 650 nm of 1 (approximately 8x108 
cells) was centrifuged at 16,300 xg for 5 minutes, and resuspended in 1 ml of 25 mM 
Tris-Cl (pH 7.5) to a final A650 of 1.0.  After an initial absorbance reading (T0), sodium 
dodecyl sulfate (SDS) was added at a final concentration of 0.1% to one set of samples 
per strain.  Samples were incubated at 37°C without aeration.  Bacterial lysis was 
recorded as the ratio of absorbance at each time point (Tn) versus the absorbance at time 




1. Role of metabolic regulators in S. flexneri pathogenesis 
During the course of infection, S. flexneri is faced with several diverse and dynamic 
environments.  To successfully establish infection, the invading bacterium must adapt to 
these environments to avoid clearance and proliferate within the host.  Several global 
regulators mediate the adaptation to variations in carbon source. To examine the role of 
carbon metabolism in S. flexneri pathogenesis, mutants were constructed in the major 
carbon flux regulators cAMP-CRP, CsrA and Cra. These regulators were chosen based 
on their documented role in E. coli carbon metabolism, colonization and persistence in 
the host. The metabolic regulators Cra and CsrA control several processes in central 
metabolism, but overlap with respect to regulation of glycolysis and gluconeogenesis 
(Fig. 11). Because of the strong genetic similarity between S. flexneri and E. coli, it is 
likely these regulators have similar functions in these two species. The constructed 




Figure 11: Regulation of central carbon metabolism by CsrA, Cra and cAMP-CRP.   
The metabolic regulators CsrA, Cra and cAMP-CRP modulate central carbon metabolism 
by regulating expression of key genes in the glycolytic and gluconeogenic pathways. 
Figure modified from Sabnis et al.  (112).  
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1.1 GROWTH AND VIRULENCE PROPERTIES OF THE CRP AND CYAA 
MUTANTS 
 
Catabolite regulation is mediated in part by the cAMP-CRP transcriptional regulator.  
To study the role of cAMP-CRP in S. flexneri pathogenesis, mutations were constructed 
in both crp and cyaA (encoding by adenylate cyclase).  The crp and cyaA mutations were 
transduced from E. coli strains JW5702 and JW3778, respectively, into wild type S. 
flexneri 2457T.  
In E. coli, the absence of the cAMP-CRP complex results in slower growth rate (25).  
To test this in S. flexneri, the growth characteristics of the crp and cyaA mutants were 
examined. Strains were grown in LB broth, and cell growth was monitored by reading the 
optical density of the cultures at regular intervals.  In comparison to wild type, the crp 
mutant demonstrated a modest reduction in growth rate (Fig. 12A).  The cyaA mutant, 
however, was significantly impaired in growth (Fig. 12B). Both mutants were able to 
recover to wild type cell density by 24 hours, but this recovery may be due to 
suppressors, as cAMP-CRP is a pleiotropic regulator necessary for several cellular 
functions.  
Glucose uptake via the phosphotransferase system inhibits adenylate cyclase 
activity, thereby preventing formation of a functional cAMP-CRP regulator (Fig. 6).  
Therefore, exogenous glucose may increase the growth rate of the crp and cyaA mutants, 
as production of the cAMP-CRP regulator should be reduced under these conditions.   To 
test this hypothesis, the crp and cyaA mutants were grown in LB broth supplemented 
with 0.2% glucose and growth was monitored. The addition of glucose modestly 
stimulated growth of the crp mutant (Fig. 12A), but did not restore growth of the cyaA 
mutant (Fig. 12B). The inability of the cyaA mutant to grow in the presence of glucose 
suggests there is an essential role of cAMP in the cell, and that this role may be 








2457T	   crp	   crp/pWCrp	   2457T	   crp	   pWCrp	  












WT cyaA WT cyaA 









Figure 12: cAMP-CRP is not essential for growth in rich media. 
Several colonies from a TSBA-CR plate were used to inoculate LB broth, and cultures 
were grown overnight with aeration at 30°C.  Overnight cultures were then subcultured to 
an A650  equal to 0.02 into fresh LB-broth with or without 0.2% glucose, and grown at 
37°C with aeration. Ampicillin was added to maintain the plasmid pWCrp where 
indicated. Growth was monitored by reading the optical density of the culture at 650 nm 
(A650) at 8 and 24 hours after inoculation. (A) End-point growth analysis of wild type 
(WT, 2457T), crp mutant (AGS170) and crp mutant carrying the complementing plasmid 




When grown on TSB agar plates supplemented with 0.01% Congo red, wild type S. 
flexneri binds the dye forming characteristic red colonies.  The ability to bind Congo red 
is an indirect indicator of invasive ability, as strains defective in Congo red binding are 
avirulent (98). The crp mutant, however, grew as smaller colonies and bound less dye, 
resulting in a characteristic pink-white color.  Similarly, the cyaA mutant, which is 
defective in cAMP production, also bound less Congo red, forming smaller, pink-white 
colonies on TSB agar. The small colonies formed by the mutants were consistent with the 
growth phenotype in LB broth.   
To examine the role of cAMP-CRP in S. flexneri pathogenesis, a cell culture invasion 
assay was used.  As indicated by their Congo red binding defects, both the cyaA and crp 
mutants were less invasive than wild type. The crp mutant invaded at 20% of the wild 
type level, and invasion was restored by expression of crp from a plasmid (Fig. 13).  In 
comparison, the cyaA mutant was noninvasive.  The decreased invasion in both strains 
suggests that cAMP-CRP is a regulator of S. flexneri pathogenesis, though the 
mechanism by which cAMP-CRP influences pathogenesis is unclear. It is likely that the 
virulence defects are due to one of the pleiotropic effects of this regulator on cellular 






Figure 13:  Decreased invasion by the crp and cyaA mutants. 
Wild type (2457T), cyaA (AGS180), crp (AGS190) and the crp complement 
(crp/pWCrp) were added to a subconfluent monolayer of Henle cells and allowed to 
invade for 1.25 hours before staining and enumeration.  A Henle cell was considered 
invaded if it contained 3+ intracellular bacteria. At least 300 epithelial cells were 
counted.   The invasion percentage of the cyaA mutant, the crp mutant and the crp 
complement (crp/pWCrp) were normalized to the invasion efficiency of the wild type 























1.2 CHARACTERIZATION OF THE CRA MUTANT 
As the bacterium transits through the host, S. flexneri likely relies on metabolic 
regulators to adapt to changing environmental conditions.  In addition to its role in 
catabolite repression (Fig. 11), the metabolic regulator Cra is required for persistence of 
EHEC in vivo (68).  To examine if Cra is also important for S. flexneri pathogenesis, the 
mutant cra allele in JW0078 was transduced into wild type S. flexneri 2457T.  
 
1.2.1 Growth and BioLog phenotypic microarray 
The in vitro growth properties of the S. flexneri cra mutant were examined first, as 
this protein likely has similar roles in both species. An E. coli cra mutant is unable to 
grow with gluconeogenic substrates as the sole carbon source (113). As predicted, the S. 
flexneri cra mutant did not grow in minimal media when the gluconeogenic carbon 
source lactate was the sole carbon source (Fig. 14B). Furthermore, this mutant had a 
slight growth defect versus the wild type strain when grown in LB broth (Fig. 14A). 
 BioLog phenotype microarrays were performed to assess differences in carbon 
source utilization of the cra mutant versus the wild type strain (Table 5).  This assay 
relies on cellular respiration as an indicator of the bacterium’s ability to use a provided 
substrate, as active respiration leads to reduction of a tetrazolium dye.  At 24 hours, the 
cra mutant had reduced absorbance readings on several gluconeogenic carbon sources, 
indicative of reduced utilization of these substrates (Table 5). In agreement with 
previously published data in E. coli, the S. flexneri cra mutant was better able to utilize 
mannose, glucose-6-phosphate, fructose and glucose (108). Increased consumption of 
these carbon sources is likely due to derepression of glycolytic gene expression in the 
absence of Cra.  There were some discrepancies between the previously published E. coli 
data and the data gathered from the S. flexneri cra mutant.  This may be due to 
differences in data collection methods, as the E. coli studies relied on visual scoring 
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Figure 14:  Growth phenotypes of the cra mutant  
 (A) The cra mutant has a slight growth defect in rich media. Strains were grown 
overnight in LB broth at 30°C, and subcultured to an A650 equal to 0.02 in 8 ml LB broth.  
Strains were grown at 37°C with aeration, and growth was monitored by reading the 
optical density (A650) at 2 hour intervals.  
(B) The cra mutant is unable to utilize gluconeogenic carbon sources for growth.  
Cultures were grown overnight at 30°C, and diluted 1:100 into MM9 with 0.2% lactate. 














   WT                            cra 
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Table 5:  BioLog phenotype microarray of 2457T (wild type) versus cra (AGS190) 
a: data from Ramseier et al.  (108). Legend: -, no color; ±, faint color; + , strong color; ++ 
very strong color. Differences of at least two-fold are shown in bold. 
 
Carbon Source Substrate type S. flexneri E. colia 
  wild type cra wild type cra 
Negative Control  negative control 0.08 0.06     
L-Aspartic Acid  amino acid 0.57 0.34     
D-Alanine  amino acid 0.7 0.07 ++ - 
L-Asparagine  amino acid 0.55 0.17 + ± 
L-Serine  amino acid 0.64 0.45     
L-Threonine  amino acid 0.34 0.09     
L-Alanine  amino acid 0.81 0.16     
Ala-Gly  amino acid 0.75 0.29     
Succinic Acid  carboxylic acid 0.52 0.36     
D-Glucuronic Acid  carboxylic acid 1.19 0.8     
D-Gluconic Acid  carboxylic acid 0.21 0.14 ++ ++ 
L-Lactic Acid  carboxylic acid 1.42 0.49     
D,L-Malic Acid  carboxylic acid 0.67 0.43     
a-Ketoglutaric Acid  carboxylic acid 0.21 0.10     
Fumaric Acid  carboxylic acid 0.62 0.37 + - 
L-Malic Acid  carboxylic acid 0.68 0.37     
Pyruvic Acid  carboxylic acid 0.6 0.74     
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D-Galacturonic Acid  carboxylic acid 1.82 1.4 + + 
Methylpyruvate  ester 0.71 0.49     
L-Arabinose carbohydrate 0.66 0.07     
N-Acetyl-D-Glucosamine carbohydrate 0.8 0.91 ++ ++ 
D-Galactose carbohydrate 0.97 0.54 ++ ++ 
D-Mannose carbohydrate 0.8 1.05 ± ++ 
Glycerol carbohydrate 1.09 0.49     
D,L-a-Glycerol Phosphate carbohydrate 0.79 0.79 ++ ± 
D-Mannitol carbohydrate 0.9 1.02 + ++ 
D-Glucose-6-Phosphate carbohydrate 1.5 1.47 + ++ 
D-Ribose carbohydrate 0.11 0.06     
D-Fructose carbohydrate 0.84 0.67 + ++ 
a-D-Glucose carbohydrate 0.65 0.95 + ++ 
D-Melibiose carbohydrate 0.97 0.12     
Thymidine carbohydrate 1.28 1.12 ++ ++ 
a-Methyl-D-Galactoside carbohydrate 0.54 0.09 ++ - 
Uridine carbohydrate 0.75 0.34 ++ ++ 
D-Glucose-1-Phosphate carbohydrate 1.33 1.29 ++ ++ 
D-Fructose-6-Phosphate carbohydrate 1.36 1.4 ++ ++ 
2'-Deoxyadenosine carbohydrate 1.03 1.34 ++ ++ 
Adenosine carbohydrate 0.63 1.09 ++ ++ 
Inosine carbohydrate 1.42 1.27 ++ ++ 
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1.2.2 Virulence properties of the cra mutant 
The S. flexneri cra mutant was assessed for its role in invasion and intracellular 
spread in a cell culture invasion assay.  In this assay, the cra mutant was approximately 
30% more invasive than wild type and demonstrated an increase in the number of 
intracellular bacteria 1.5 hours post-invasion (Fig. 15). Based on this phenotype, it was 
proposed that the absence of cra increased S. flexneri adherence or increased the rate of 
intracellular replication.  However, both the brevity of the invasion assay and the in vitro 
growth phenotype of the mutant argued that the increased invasion was more likely due 
to an increase in attachment to host cells.   In agreement with this hypothesis, the cra 
mutant was approximately 7-fold more adherent than wild type (Fig. 16).   
The role of cra in plaque formation was also examined, as metabolic regulation may 
be needed for survival in the host cytosol. Although the cra formed approximately the 
same numbers of plaques as the wild type, the plaques formed by the mutant were 
generally smaller and more turbid (Fig. 17A).  The turbidity of the plaques was 
suggestive of incomplete lysis of the monolayer. 
Because plaque formation is a multistep process, both intracellular replication and 
intercellular spread were assayed. To rule out differences in intercellular spread as a 
primary cause of defective plaque formation, IcsA localization was examined. Cultures 
were grown as in the invasion assay, and immunostained with anti-IcsA antibody, and 
labeled with FITC secondary antibody. IcsA localization was then detected by 
immunofluorescence microscopy. When grown in vitro, there was no obvious difference 
in the polar localization of IcsA in the cra mutant versus the wild type strain (Fig. 17B), 
arguing against defects in actin-based motility.  
The intracellular replication of the cra mutant was also examined, as failure to 
replicate within the host cell could lead to defects in plaque formation.  To determine 
intracellular replication, the invasion assay was done as described in methods, reducing 
the number of cra mutant bacteria added by a factor of 5 to compensate for the increased 
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invasion of this strain. The number of intracellular bacteria was determined over time by 
counting bacteria per Henle cell by microscopy and by plating.  Within a subconfluent 
monolayer of epithelial cells, the cra mutant did not demonstrate any discernable 
difference in replication compared to the wild type (data not shown).   
The above data argue against intracellular replication defects as a cause of 
aberrant plaque formation by the cra mutant.  However, the morphology of the cra 
mutant within the host cell was examined, as the plaque defect may be caused by failure 
of the cra mutant to escape to the host cytosol, or other abnormalities of the mutant 
within the intracellular environment. Microscopic analysis of the cra mutant within a 
confluent monolayer of Henle cells revealed the presence of several bacteria within 
vacuoles in comparison to the wild type (Fig. 17C). These anomalies may be 
representative of inefficiencies or intracellular defects of the cra mutant that could 






Figure 15:  Cra inhibits S. flexneri invasion.   
A) S. flexneri invasion increases 30% in the absence of cra.  The invasion percentages of 
the cra mutant and complements were normalized to that of the parental strain 2457T 
(wild type).  The cra mutant was complemented by expression of S. flexneri cra from the 
low-copy vector pWKS30. Data shown is the average of three independent experiments, 
and error bars represent standard deviation.  The relative invasion of the mutant and wild 
type were compared using an unpaired student’s T-test.  ** represents a P-value < 0.01. 






Figure 16:  S. flexneri attachment to eukaryotic cells is affected by CsrA and Cra 
The total number of bacteria attached to 100 Henle cells was counted by microscopy for 
each strain.  Values shown are the average of three independent experiments, and are 
normalized against the wild type within each experiment.  Error bars represent standard 
deviation.  Unpaired student’s T-test was used to compare the relative attachment of the 
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(A) The cra mutant forms turbid plaques in comparison to wild type (WT).  Cultures 
were inoculated and grown as in the invasion assay.  Approximately equal numbers of 
cells (2x108 cells) were used to inoculate a confluent monolayer of Henle cells. Bacteria 
were spun onto the monolayer for 10 minutes, then allowed to invade for 45 minutes.  
Monolayers were then overlayed with media containing gentamycin, and incubated for an 
additional 48 hours prior to washing and staining.  
(B) IcsA localization in the cra mutant. Strains were grown to exponential phase in LB 
broth, and fixed and immunostained with anti-IcsA (VirG) antibody, followed by labeling 
with FITC secondary antibody.  Signal was detected by fluorescence microscopy. There 
was no discernable difference in polar localization of this protein in the wild type and 
mutant strain.  
(C) Unique morphology of cra mutant within Henle cell.  Strains were grown and 
inoculated in a confluent monolayer of epithelial cells as outlined in (A). After a 90 
minute incubation, monolayers were washed and stained. Box: microcolonies; Arrows: 
vacuolar bacteria. 
 




1.3 CHARACTERIZATION OF THE ROLE OF CSRA IN S. FLEXNERI 
 
The phenotype of the S. flexneri cra mutant suggests that disruptions in carbon 
metabolism affect both invasion and plaque formation.  Because Cra and CsrA exert 
opposing effects on carbon metabolism (Fig. 11), it was predicted that disruption of csrA 
in S. flexneri would inhibit invasion. To examine if csrA is also important for S. flexneri 
pathogenesis, an S. flexneri csrA mutant was constructed and tested in the cell culture 
assays.  
1.3.1 Growth and metabolic properties of the csrA mutant 
The role of CsrA in S. flexneri had not been empirically assessed.  To determine if 
CsrA has similar roles in E. coli and S. flexneri, the in vitro growth properties of the S. 
flexneri csrA mutant were examined. In LB broth there was no obvious growth difference 
between the S. flexneri wild type and csrA mutant strains, a phenotype also noted with the 
E. coli csrA mutant (110).  A defining characteristic of E. coli csrA mutants is an increase 
in internal glycogen stores (146).  The csrA mutant has the same effect on glycogen 
metabolism in S. flexneri (Fig. 18), indicating that CsrA represses glycogen metabolism 
in both E. coli and S. flexneri.  
 In the BioLog phenotype microarrays, the csrA mutant was better able to utilize 
adenosine and 2-deoxyadenosine, and also showed increased consumption of the 
gluconeogenic carbon sources pyruvate, fumarate and bromosuccinate. The csrA mutant 
characteristically was less able to metabolize several glycolytic carbon sources (Table 6), 
which is consistent with the role of this protein in activation of glycolytic gene 
expression.  However, the reduction in glycolytic carbon source utilization did not apply 
to all glycolytic carbon sources examined, including mannose, fructose and glucose 




Table 6: BioLog phenotype microarray of 2457T versus csrA (AGS120).   
Differences of at least two-fold are shown in bold. 
Carbon Source Substrate Type wild type csrA 
Negative Control  negative control 0.08 0.09 
L-Arabinose  carbohydrate 0.66 0.45 
N-Acetyl-D-Glucosamine  carbohydrate 0.8 0.68 
Succinic Acid  carboxylic acid 0.52 0.66 
D-Galactose  carbohydrate 0.97 0.82 
D-Trehalose  carbohydrate 1.12 0.81 
D-Sorbitol  carbohydrate 0.09 0.68 
D-Glucuronic Acid  carboxylic acid 1.19 0.93 
D-Gluconic Acid  carboxylic acid 0.21 0.42 
D-Mannitol  carbohydrate 0.87 0.73 
D-Glucose-6-Phosphate  carbohydrate 1.52 1.39 
D-Ribose  carbohydrate 0.11 0.4 
D-Fructose  carbohydrate 0.84 0.98 
a-D-Glucose  carbohydrate 0.65 0.7 
L-Asparagine  amino acid 0.55 0.78 
a-Ketoglutaric Acid  carboxylic acid 0.21 0.41 
Uridine  carbohydrate 0.75 0.52 
D-Glucose-1-Phosphate  carbohydrate 1.33 1.24 
D-Fructose-6-Phosphate  carbohydrate 1.36 1.28 
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2'-Deoxyadenosine  carbohydrate 1.03 1.5 
Adenosine  carbohydrate 0.63 1.23 
Gly-Asp  amino acid 0.42 0.53 
Fumaric Acid  carboxylic acid 0.62 0.82 
Bromosuccinic Acid  carboxylic acid 0.42 0.69 
Gly-Glu  amino acid 0.43 0.26 
L-Serine  amino acid 0.64 0.74 
L-Threonine  amino acid 0.34 0.25 
L-Alanine  amino acid 0.81 0.96 
Ala-Gly  amino acid 0.75 0.92 
Acetoacetic Acid  carboxylic acid 0.09 0.21 
Mono-Methylsuccinate  carboxylic acid 0.17 0.3 
Methylpyruvate  ester 0.71 0.8 
L-Malic Acid  carboxylic acid 0.68 0.72 







Figure 18:  Glycogen accumulation in the Csr mutants.   
Strains were streaked onto Kornberg agar containing 2% glucose and incubated overnight 
at 37°C.  Internal glycogen stores were detected by staining with iodine vapor for 15 – 30 
seconds.  The intensity of staining is proportional to the level of internal glycogen.  The 




1.3.2 Virulence properties of the csrA mutant 
Homologs of CsrA have multiple roles in pathogenesis (Table 1), and it has been 
proposed that this protein may coordinate physiological traits with progression through 
the virulence cycle (72). To determine if CsrA also regulates S. flexneri pathogenesis, the 
S. flexneri csrA mutant was tested for both invasion and plaque formation. When grown 
on TSB agar containing Congo red, the S. flexneri csrA mutant produced a mix of 
strongly and weakly pigmented colonies. Complementation of the csrA mutant using 
either the IPTG-inducible plasmid pQCsrA or the low-copy pWCsrA restored Congo red 
binding to near-wild type levels. This variation in Congo red binding may be due to 
variations in the level of CsrA activity in the mutant strain.   
In comparison to wild type, the csrA mutant demonstrated a significant reduction in 
both attachment and invasion (Figs. 16, 19).  Complementation of the csrA mutant with 
pWCsrA only restored invasion of the mutant to approximately 20% of the wild type 
level.  Induction of csrA from the IPTG-inducible promoter in pQCsrA restored invasion 
to 50% of wild type (Fig. 19).   
As expected from the defect in invasion, the csrA mutant formed fewer plaques than 
wild type. The plaques formed by this mutant were also characteristically smaller and 
more turbid than wild type, indicative of defects in intracellular replication or 
intercellular spread (Fig. 20).  The defect in plaque formation may be due to 
misregulation of carbon metabolism of bacteria residing within the eukaryotic cytosol.  
Complementation of the csrA mutant in the plaque assay with pQCsrA increased the 
number plaques formed, but these plaques were still smaller and more turbid in 
comparison to wild type.  This incomplete complementation may be due to inherent 
difficulties in maininting the plasmid within the host cell, or to more general inhibition of 
wild type CsrA dimers. Timmermans et al. (128) have shown residual activity of the 
csrA::kn allele, which is still able to dimerize and regulate mRNA stability. The 
difficulties in complemenation of the S. flexneri csrA mutant may, therefore, be due to the 
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formation of less functional complexes that interfere with formation and activity of wild 







The csrA mutant invaded at approximately 5% of the wild type level. In the presence of 
IPTG, expression of csrA from the plasmid pQCsrA restored invasion of the csrA mutant 
to approximately 50% of the wild type level. The vector pQE2 was included as a control. 
Invasion was normalized to the percent invasion of the wild type strain in each 
experiment. Data shown is the average of three independent experiments performed in 
triplicate. Error bars represent standard deviation. Samples were compared using an 
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Figure 20:  Decreases in free CsrA inhibit plaque formation.  
A) Disruption of csrA decreases the number of plaques formed and the size and clarity of 
the plaques.  Approximately 104 cells were added to a confluent monolayer of Henle 
cells, and monolayers were stained after 72 hours. B) The csrD mutant formed fewer 
plaques than wild type, but the plaques had wild type morphology.  105 cells were added 




1.3.3 Overexpression of csrA in S. flexneri 
In S. Typhimurium, it has been shown that the level of CsrA must be carefully 
regulated, as both deletion and overexpression of csrA are inhibitory to invasion in vitro 
(4).  Therefore, the effect of CsrA overexpression on S. flexneri invasion was also 
examined.  Overexpression of csrA in S. flexneri from the IPTG-inducible plasmid 
pQCsrA significantly inhibited invasion (Fig. 21).  This suggests that CsrA may have 
dual roles in S. flexneri pathogenesis, specifically as an inhibitor and activator of 
virulence properties.  The inhibitory effect of CsrA overexpression on S. flexneri invasion 
may be due to disruptions in timing of CsrA expression, as this protein is 
characteristically expressed upon entry into stationary phase.  Overexpression of csrA in 
wild type S. flexneri may therefore cause misregulation of genes necessary for efficient 
invasion. 
1.4 CSRA REGULATORS AND S. FLEXNERI VIRULENCE 
In E. coli, the level of free CsrA is governed by an autoregulatory loop that includes 
two antagonistic RNAs and the BarA-UvrY two component system (Fig. 9). Based on the 
phenotype of the S. flexneri csrA mutant, it was predicted that a reduction in the level of 
CsrA would inhibit invasion.  Conversely, increased amounts of CsrA were predicted to 
increase invasion, as increased glycolysis correlated with increased invasion in the cra 
mutant (Fig. 15). To better understand the role of CsrA in S. flexneri pathogenesis, 
mutations were constructed in each of the known regulatory elements and tested in the 




Figure 21:  Overexpression of csrA in wild type S. flexneri inhibits invasion.   
Wild type S. flexneri carrying the empty vector pQE2 or the IPTG-inducible csrA 
construct pQCsrA were tested in the invasion assay, and values are normalized to the 
wild type strain carrying the empty vector in the absence of IPTG.  The addition of 
200µM IPTG decreased invasion S. flexneri carrying pQCsrA to approximately 40% of 
























1.4.1 Overexpression of csrB and csrC 
The ncRNAs CsrB and CsrC inhibit CsrA activity by binding to the protein, 
effectively sequestering it away from its targets.  Because of the antagonistic roles of 
both ncRNAs, it was postulated that overexpression of either csrB or csrC would lead to 
a decrease in the level of CsrA protein, thereby inhibiting S. flexneri invasion.  In 
agreement with this hypothesis, overexpression of csrB or csrC from the IPTG-inducible 
plasmids pQCsrB and pQCsrC respectively, decreased S. flexneri invasion to 
approximately 50% of S. flexneri carrying the empty vector (Fig. 22).  This agrees with 
the model of CsrA regulation as outlined in E. coli, and further implicates CsrA as an 
important regulator of S. flexneri virulence. 
1.4.2 Deletion of csrB and csrC 
Based on the E. coli model of CsrA regulation, deletion of either csrB or csrC should 
alleviate CsrA repression (Fig. 9).   This was confirmed for the S. flexneri mutants, as 
both the csrB and csrC mutants showed a decrease in internal glycogen stores when 
grown in high concentrations of glucose (Fig. 18).  Both the csrB and csrC mutants were 
more invasive than wild type (Fig. 24).  The relatively modest difference in invasion is 
likely due to compensatory increases in expression of one RNA in the absence of the 
other (143), but is consistent with the role of these ncRNAs in inhibition of CsrA activity. 
Despite the increases in invasion, there was no difference in plaque formation by either 
mutant. This may be due to expression patterns of the ncRNAs when the bacteria are 
growing within the epithelial cell or a consequence of the modest effects of each mutant 
on CsrA levels. 
In E. coli, glucose activates csrC expression independently of the response-regulator 
UvrY, but has no effect on expression of csrB (59). To test if this phenomenon also 
occurs in S. flexneri, 0.2% glucose was added to cultures grown in LB broth prior to 
invasion.  If glucose does stimulate csrC expression in S. flexneri, it should decrease the 
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level of free CsrA and inhibit invasion in the csrB mutant. When grown in the presence 
of glucose, the csrB mutant exhibited wild type levels of invasion (Fig. 23).  The relative 
decrease in invasion efficiency in the presence of glucose agrees with increased 
expression of csrC.  As predicted, the addition of glucose to the growth media had no 




Figure 22:  Overexpression of csrB or csrC inhibits invasion.   
In the presence of 200µM IPTG, expression of csrB or csrC inhibits invasion.  The 
inducer molecule IPTG was added 15 minutes prior to proceeded with the normal 
invasion assay, and was maintained in the media throughout the assay. Values shown are 
relative to the wild type invasion value under the same conditions.  Data shown are the 


























Figure 23:  Glucose represses the invasion phenotype of the csrB and uvrY mutants. 
Strains were grown in LB broth with (+) or without (-) 0.2% glucose to exponential phase 
prior to proceeding with the invasion assay.  The invasion percentages shown have been 
normalized to the wild type invasion under the same conditions.  Data shown are a 
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The inner membrane protein CsrD stimulates turnover of both CsrB and CsrC.  Thus, 
in the absence of this protein, both the csrB and csrC messages are more stable and the 
level of free CsrA decreases (59, 125). In the glycogen accumulation assay, the csrD 
mutant stained less intensely compared to wild type (Fig. 18). This phenotype is 
inconsistent with the regulatory model, which suggests that the absence of csrD should 
decrease the level of free CsrA, thereby increasing internal glycogen stores.  As CsrD is a 
predicted inner membrane protein, the absence of this gene could alter membrane 
properties such that internal glycogen stores may not be detected by iodine staining.   
The csrD mutant was defective in Congo red binding, a phenotype noted in the csrA 
mutant.  As suggested by the defect in Congo red binding, the csrD mutant was 
approximately 60% less invasive than wild type (Fig. 24). The absence of csrD led to a 
90% reduction in the number of plaques formed, but these plaques appeared normal (Fig. 
20).  The decrease in invasion and plaque number are consistent with CsrD acting as a 
regulator of CsrB and CsrC degradation. 
1.4.4 UvrY  
In response to phosphorylation by BarA, the response regulator UvrY activates 
expression of both csrB and csrC, which in turn inhibit CsrA activity (126).  Therefore, 
the absence of uvrY should alleviate inhibition of CsrA, subsequently reducing glycogen 
accumulation and increasing S. flexneri invasion. As expected, the S. flexneri uvrY mutant 
had decreased glycogen stores relative to wild type (Fig. 18).   
In the invasion assay, the uvrY mutant was 40% more invasive than wild type (Fig. 
24), and this increase in invasion was coupled with an increase in the number of cytosolic 
bacteria. The increase in invasion by the uvrY mutant is likely due to a three-fold increase 
in attachment (Fig. 16).  As was seen with the csrB mutant, the addition of glucose to the 
growth media blocked the invasion increase, presumably due to increased CsrA inhibition 
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by CsrC (Fig. 23). There was no phenotype of the uvrY mutant with respect to plaque 
formation.  Normal plaque formation in this mutant may be due to the presence of 
glucose in the tissue culture media, which could induce csrC expression, thereby 
restoring function of the Csr modulon (59).  
1.4.5 BarA  
In response to an unknown stimuli, BarA autophosphorylates and transfers this 
phosphate group to its cognate response regulator UvrY.  If the overall model of CsrA 
regulation is correct (Fig. 9), then disruption of barA in S. flexneri should lead to 
decreased activation of UvrY, subsequently decreasing expression of csrB and csrC, and 
alleviating CsrA repression. There was no discernable difference in iodine staining 
between the wild type and barA mutant when grown on Kornberg agar with glucose (Fig. 
18). Deletion of barA did not affect S. flexneri invasion (Fig. 24) or plaque formation.  
The absence of a discernable phenotype may be due to promiscuous activation of the 
response regulator. In the barA mutant, the orphaned response regulator may be 
phosphorylated by another histidine kinase or a small phospho-donor (140), thereby 




Figure 24: Regulators of CsrA also influence invasion.   
Decreases in the level of free CsrA (e.g. csrD mutant) decrease S. flexneri invasion 
effiency, whereas mutations that increase the amount of free CsrA (e.g. uvrY, csrB, csrC 
mutants) increase invasion.  Values are normalized to the invasion percentage of the wild 
type, and data presented are the average of at least three independent experiments. Error 
bars represent standard deviation.  Unpaired student’s T-test was used compare the 
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2. Central Carbon metabolism and S. flexneri pathogenesis 
The phenotypes of the CsrA and Cra mutants suggest that regulation of the central 
carbon metabolic pathways is important invasion and persistence of S. flexneri within the 
host cell. While both pathways appear to be important for plaque formation, increased 
expression of glycolytic genes, as seen in the uvrY and cra mutants, correlated with 
increased attachment and invasion. To directly examine the role of glycolysis and 
gluconeogenesis in S. flexneri pathogenesis, mutants were constructed in a key step of 
each pathway, and these mutants were examined for invasion and plaque formation. 
 
2.1.1 Gluconeogenesis 
The enzyme phosphoenolpyruvate synthase (Pps, encoded by ppsA) catalyzes one 
of the committed steps of gluconeogenesis (Fig. 11).  Expression of ppsA is activated by 
Cra, but repressed by CsrA. The phenotypes of the csrA and cra mutants suggested a 
correlation between decreased gluconeogenesis and increased invasion. To study the 
contribution of gluconeogenesis in pathogenesis, a ppsA mutant allele in JW1692 was 
transduced into wild type S. flexneri.  The absence of ppsA had no effect on S. flexneri 
growth in LB broth.   In the invasion assay, the ppsA mutant was as invasive as the 
parental strain (Fig. 25).  Although these data suggests that Pps and gluconeogenesis are 
not crucial for invasion, deletion of ppsA only inhibits one pathway by which PEP can be 
generated. Therefore, a double mutant in a redundant pathway may be needed to 




Figure 25: The absence of glycogen biosynthesis increases S. flexneri invasion.   
The glgC mutant, which is defective in the first step in glycogen biosynthesis, was more 
invasive than wild type.  Disruption of the gluconeogenic gene ppsA had no significant 
effect on invasion.  The percent invasion shown is relative to wild type, and data given 
are the average of at least three independent experiments. An unpaired student’s T-test 
was used to compare the percent invasion of the mutant strains relative to wild type. * 























The glycolytic enzyme phosphofructokinase (Pfk) catalyzes one of the first 
committed steps in glycolysis (Fig. 11).  Although there are two isozymes, PfkI (encoded 
by pfkA) is the major isozyme, and is responsible for 90% of the Pfk activity in E. coli 
(48).  The reciprocal phenotypes of the csrA and cra mutants suggested a strong 
correlation between increased glycolysis and increased invasion by S. flexneri.  To 
directly examine the effects of glycolysis on S. flexneri pathogenesis, the pfkA mutant 
allele in JW3887 was transduced into wild type S. flexneri. Consistent with the role of 
PfkI in glycolysis, the pfkA mutant was unable to grow in M63 minimal media when 
glucose was the sole carbon source (Fig. 26A).  The mutant grew as well as wild type on 
the gluconeogenic carbon source lactate, but exhibited a slight growth defect in LB broth 
(Fig. 26B).  
 When grown on Congo red agar, the S. flexerni pfkA mutant grew as pink 
colonies, similar to those formed by the csrA mutant.  Consistent with the Congo red 
binding defect, the pfkA mutant was completely avirulent in both the invasion (Fig. 27) 
and plaque assays.  Both plaque formation and invasion were complemented by 
expression of pfkA in the vector pWPfkA.   
PfkI is required for metabolism of carbon substrates that enter at or above fructose-6-
phosphate in the glycolytic pathway (Fig. 11) (137) .  If the defect in utilization of 
glycolytic carbon sources is the cause for the avirulent phenotype of the pfkA mutant, 
then growth in a gluconeogenic carbon source may supersede this defect.  Growth of the 
pfkA mutant in minimal medium with either pyruvate or lactate did not restore invasion 
by this strain (Fig. A1).  This result is not completely unexpected, as the pfkA mutant 
likely metabolizes gluconeogenic carbon sources for growth in LB broth and is 
noninvasive under these conditions (Fig. 27).  These data suggests that either a glycolytic 








































Figure 26:  The pfkA mutant grows poorly when glucose is the sole carbon source.   
Overnights were grown at 30°C in LB broth, then subcultured to a starting absorbance 
(A650) of 0.02 in M63 with 0.2% glucose (A) or LB broth (B).  Cultures were grown at 




Figure 27:  The pfkA mutant is noninvasive.  
 In the invasion assay, the pfkA mutant AGS220 was noninvasive, and invasion was 
restored by expression of wild type pfkA from its native promoter on the plasmid 
pWPfkA.  Invasion percentages shown are relative to the wild type, and data given are 
the average of three independent experiments.  Unpaired student’s T-test was used to 
compare the invasion of the mutant strain relative to wild type.  ** denotes P-value < 




















	  	  **	   	  	  	  	  **	  
	  	  	  	  	  	  	  	  **	  
109 
 
2.1.3 Glycogen metabolism  
Because of the role of CsrA in glycogen metabolism (Fig. 9), it was also possible that 
the invasion phenotypes seen in the csrA mutant were due to disruptions in either 
synthesis or degradation of this polysaccharide. To directly test the role of glycogen in S. 
flexneri pathogenesis, a mutation was constructed in the first step of the glycogen 
biosynthetic pathway (glucose-1-phosphate adenylyltransferase, encoded by glgC).  
Deletion of glgC had no effect on S. flexneri growth in rich media.  However, in the 
invasion assay, the glgC mutant was over 60% more invasive than wild type (Fig. 25).  
This phenotype is opposite that seen in the csrA mutant, which suggests that the invasion 
defect of the csrA mutant is not due to blocks in glycogen biosynthesis.  The increased 
invasion of the glgC mutant may be due to reallocation of carbon skeletons in the absence 
of glycogen synthesis.  Carbon resources in the glgC mutant may be siphoned to other 
biosynthetic pathways that enhance the overall fitness of the bacterium, thereby 
increasing invasion.  No obvious differences were seen in plaque number or morphology, 
suggesting that glycogen is not a crucial carbon source for S. flexneri in the cell culture 
assays. This, however, does not rule out a role for glycogen stores in vivo, as the cell 
culture media used contains an excess of glucose.  Glycogen may play an important role 
in S. flexneri survival as it competes with resident microbes in the lumen, or as the 
bacterium transits the host gastrointestinal tract. 
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3. Effects of glycolysis on S. flexneri physiology and virulence gene 
expression 
3.1 CARBON METABOLISM AND THE S. FLEXNERI OUTER MEMBRANE  
LPS and O-antigen have an important role in S. flexneri pathogenesis.  O-antigen 
polysaccharide length is important for invasion, as longer molecules can mask the type III 
secretion system (144).   LPS is also important for actin-based motility, as mutants 
lacking the O-antigen exhibit aberrant IcsA localization (117, 118, 134).  Because of the 
role of LPS in S. flexneri virulence, it was proposed that changes in carbon metabolism 
might lead to changes in the LPS, thereby affecting pathogenesis.  To better understand 
the mechanism by which carbon metabolism affects S. flexneri pathogenesis, the outer 
membrane profile of the csrA, cra and pfkA mutants were examined. 
3.1.1 Detergent resistance is increased in the pfkA and csrA mutants 
Resistance to the detergent sodium dodecyl sulfate (SDS) assesses differences in the 
outer membrane composition or permeability, as modifications in the outer membrane 
make strains more or less resistant to lysis by the detergent. In comparison to wild type S. 
flexneri, both the pfkA and csrA mutants were more resistant to SDS (Fig. 28). Hong et al. 
(53) have shown a correlation between detergent sensitivity and Congo red binding. The 
increased detergent resistance noted in the csrA and pfkA mutants is consistent with this 
observation, as both mutants were also impaired in Congo red binding. Detergent 
sensitivity was also tested in the cra mutant.  However, there was no difference in SDS 




Figure 28:  The csrA and pfkA mutants are more resistant to detergent as compared 
to wild type.    
Bacteria were grown to exponential phase in LB, and equal numbers of bacteria were 
resuspended in 1 ml of 25 mM Tris-Cl (pH 7.5). After an initial absorbance reading (T0), 
sodium dodecyl sulfate (SDS) was added at a final concentration of 0.1% to one set of 
samples per strain, and samples were incubated at 37°C without aeration.  Absorbance 
was recorded at the time points indicated (Tn) and sensitivity to detergent lysis is 
expressed as a percentage (A650 at Tn/A650 at Tn =  % relative A650).  Data shown is the 
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3.1.2 Lipopolysaccharide profiles are affected by CsrA and PfkA 
To examine specific effects of glycolysis on the outer membrane, LPS was harvested 
from the csrA, cra and pfkA mutants.  Bacteria were grown as in the invasion assay, and 
LPS was collected from cell extracts treated with proteinase K.  Samples prepared from 
equal numbers of cells were electrophoresed on a tricine SDS-PAGE gel and visualized 
by silver staining. 
The less invasive csrA and pfkA mutants produced LPS banding patterns in which 
each repeat unit migrated faster than that of wild type (Fig. 29A).  There was no 
significant difference in LPS migration of the avirulent, Congo red binding negative 
strain SA101 compared to wild type (Fig. A4), suggesting that the altered LPS was due to 
differences in metabolism rather than a general effect of decreased virulence gene 
expression. Because longer O-antigen can mask the type III secretion system, the amount 
of mode B O-antigen was also examined. Immunoblotting with Shigella group B antisera 
did not reveal differences in the amount of very long LPS produced by either the csrA or 
pfkA mutant (Fig. 29B).   
 The shift in LPS noted in the csrA and pfkA mutants is indicative of changes in the 
lipid A or core region of LPS. To examine the core more directly, immunoblotting was 
also performed using the Shigella group B core specific antibody MASF R3 core-1 (19).  
This antibody recognizes the R3 core type found in S. flexneri 2a strains. Under the 
conditions used, there was no difference in reactivity of the pfkA and csrA mutants as 
compared to wild type (Fig. 29C).  Changes in the core polysaccharide were also tested 
by examining changes in resistance to novobiocin, as modifications in heptose 
phosphorylation in the core affect sensitivity to this antibiotic (147).  Consistent with the 
immunoblotting data, there was no difference in novobiocin resistance in the csrA and 
pfkA mutants versus the wild type.  These data suggest that the difference in LPS 
electrophoretic mobility may be due not to changes in the core polysaccharide, but rather 
to changes in the lipid A portion of the molecule. 
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Despite the increase in invasion, there was no discernable difference in the LPS 
profile of the cra mutant versus the wild type. Since LPS is also important for actin-based 
motility, the LPS was also collected from the cra mutant growing within in the host 
cytosol. Although earlier data argued against IcsA localization defects, it was possible 
that the defect in intracellular spread occurs within the context of the host cytosol.  
Strains were allowed to replicate in a confluent monolayer of epithelial cells for 2 hours 
before collection and sample preparation.  Under these conditions, the LPS profiles of the 
cra mutant and wild type were similar (Fig. A2), suggesting that disruption of cra affects 





Figure 29:  Lipopolysaccharide profiles are altered in the pfkA and csrA mutants.  
 LPS was harvested using the protocol of Hitchcock and Brown (51) and visualized by 
(A) silver staining or immunoblotting using (B) anti-group B Shigella, which recognizes 
the mode B repeats or (C) anti-2a antibodies, which bind the core polysaccharide. 
Abbreviations:  core: lipid A plus the core polysaccharide; A: mode A, core conjugated to 
11-17 O-antigen repeat units; B: mode B, core conjugated to 90+ O-antigen repeat units. 
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3.2 EXPRESSION AND SECRETION OF IPA PROTEINS IS INHIBITED BY 
DISRUPTIONS IN GLYCOLYSIS 
 
Disruptions in glycolysis, either by mutation of the CsrA or Cra regulators or the 
glycolytic enzyme PfkI significantly affected S. flexneri invasion in the cell culture 
model. The virulence proteins IpaB and IpaC are central to S. flexneri attachment and 
invasion.  Upon contact with the host cell, IpaB and IpaC form a pore in the host cell 
membrane that promotes phagosome lysis and bacterial uptake.  Because of the primary 
role of these proteins in the preliminary steps of invasion, it was proposed that either 
expression or secretion of these proteins might be altered in the mutants.   
3.2.1 Effector secretion is reduced in the csrA and pfkA mutants 
To examine differences in effector secretion, strains were grown as for the virulence 
assays.  Equal numbers of cells were collected by centrifugation and resuspended in 
phosphate-buffered saline.  Effector secretion was induced by adding Congo red to the 
cell suspension, as this induces a burst of effector secretion similar to that seen upon host 
cell contact (106).  Secreted proteins were precipitated from the media and 
electrophoresed on an SDS-PAGE gel.  The recovered proteins were visualized by silver 
staining or immunoblotting with monoclonal anti-IpaB or anti-IpaC antibodies.  
There was no significant difference in the amount of Ipa protein secreted by the cra 
mutant (Fig. 30), arguing that gross over-secretion of the Ipa proteins is not responsible 
for the hyperinvasive phenotype seen in this strain. However, secretion was greatly 
reduced in the less-invasive csrA and pfkA mutants (Fig. 30).  From these data, it was 
concluded that decreased secretion of IpaB and IpaC is a contributing factor in the 






Figure 30: Ipa secretion is reduced in the pfkA and csrA mutants.  
Bacteria were grown to exponential phase in LB broth, and secretion was induced by 
adding 0.005% (w/v) Congo red to equal numbers of bacteria.  Secreted proteins were 
visualized by silver staining (A) or transferred to a nitrocellulose membrane and 
hybridized with anti-IpaB or anti-IpaC monoclonal antibodies (B).  
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3.2.2 Effector production is also reduced in the csrA and pfkA mutants 
To test if the defect in Ipa secretion seen in the pfkA and csrA mutants was due to a 
defect in Ipa synthesis, whole cell lysates were resolved on an SDS-PAGE gel and 
visualized by Coomassie staining or immunoblotting with monoclonal anti-IpaB or anti-
IpaC antibodies.  
Deletion of cra had no effect on the level of IpaB or IpaC produced (Fig. 31). 
Because of the plaque phenotype, Ipa production of the cra mutant within the host 
cytosol was also examined.  After 2 hours growth in a confluent monolayer, bacteria were 
collected from the host cell, and cell lysates were prepared from the recovered bacteria.  
The cra mutant made similar levels of IpaB and IpaC as the wild type (Fig. A3). Because 
the absence of cra does not affect Ipa production or secretion, is likely that this protein 
regulates invasion in an Ipa-independent fashion.  
There was a significant reduction in IpaB and IpaC levels in the csrA and pfkA 
mutants, which accounts for the decreased secretion noted in these strains (Fig. 31). In 
both strains, Ipa production was restored by expression of the wild type gene from a 
plasmid. The reduction in Ipa production seen in the csrA and pfkA mutants suggests a 






Figure 31: Decreased glycolytic gene expression results in decreased Ipa production. 
(A) Proteins were harvested from whole cell lysates and separated by SDS-PAGE 
electrophoresis and visualized by coomassie staining. (B). Collected proteins were 





3.3  DISRUPTIONS IN GLYCOLYSIS INFLUENCE VIRB AND VIRF 
EXPRESSION 
3.3.1 virB expression is reduced in the pfkA mutant 
 
The virulence regulator VirB directly activates expression from the 31-kb entry locus, 
including the ipaBCDA operon (1).  Thus, the reduced Ipa production in the csrA and 
pfkA mutants (Fig. 31) is likely due to decreased transcription of virB. To examine if virB 
expression is reduced in the pfkA mutant, bacteria were grown under the same conditions 
as the cell culture assays.  RNA was collected, and the relative expression level of virB 
was determined by real-time PCR.  The pfkA mutant was chosen for study, as this 
mutation more directly examines the effects of glycolysis on expression from the 
virulence plasmid. In comparison to the wild type, expression of virB was significantly 
reduced in the pfkA mutant (Fig. 32A), suggesting that glycolysis is required for 
expression of this virulence regulator.  
3.3.2 Expression of the virulence regulator virF is also reduced in the 
pfkA mutant 
 In response to environmental stimuli (11, 103, 130, 131), the primary virulence 
regulator VirF activates expression of virB, thereby activating expression from the entry 
locus (Figs. 2, 3). Therefore, reduced virF expression in the pfkA mutant may account for 
reduced expression of virB. Consistent with the model, the relative expression of virF 
was significantly reduced in the pfkA mutant (Fig. 32B). Thus, the invasion deficiencies 
of this strain are due principally to reduced expression of the master virulence regulators. 
Insufficient activation of virF and virB prevents expression of the ipa-mxi-spa type III 
secretion system, rendering the pfkA mutant noninvasive.  These data suggest a 
correlation between glycolytic metabolism and activation of the virulence gene cascade.  
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Carbon metabolism or carbon source availability may therefore be an additional factor by 






























































Figure 32: Expression of virF and virB is reduced in the pfkA mutant. 
Real-time PCR was used to examine relative expression of virB (A) and virF (B).  Values 
are normalized to the internal control dksA in each sample, and values are normalized to 
the expression value in wild type.  Data are the average of three independent experiments, 
and error bars represent standard deviation. An unpaired student’s T-test was used to 
compare relative expression of virB and virF. ** indicates P-values < 0.01,  * represents 




In order to establish infection, an invading pathogen must (1) colonize and penetrate 
the host mucosal surfaces (2) subvert the immune response and (3) grow within the host 
(123).   Growth is the keystone of all successful infections, as virulence progression is 
predicated on replication and proliferation of the pathogen. Growth of the invading 
pathogen is significantly influenced by the surrounding milieu.  The environmental 
conditions within the host are dynamic and shaped by the metabolic demands of both 
resident microbes and the invading bacterium. Therefore, to successfully establish 
infection, a pathogen must respond and adapt to these unique environments. 
Within the mammalian colon, S. flexneri transitions from the intestinal lumen, to the 
subepithelial spaces and ultimately replicates within colonocytes.  The bacterium must 
therefore adapt to these distinct environments.  In vitro, the shift from growth in media to 
the eukaryotic cytosol results in significant changes in S. flexneri gene expression (73).  
In addition to regulation of dedicated virulence factors, transition into the host cytosol 
results in differential regulation of several classes of metabolic genes.  This shift in 
expression is indicative of a coordinated response to the new environment. In the 
intracellular environment, S. flexneri downregulated expression of several glycolytic 
genes while upregulating expression of key genes in the gluconeogenic pathway (73).  
These data indicated that coordination of central carbon metabolism is required for 
successful adaptation to the host cytosol, and may be essential for pathogenesis.  As such, 
this study focused on the known regulators of the glycolytic and gluconeogenic pathway, 
and the effects of metabolic disruptions on S. flexneri pathogenesis in vitro.    
1. Decreased glycolysis inhibits initial stages of pathogenesis 
Glycolysis is important for the preliminary steps of S. flexneri pathogenesis, as the 
csrA and pfkA mutants are severely impaired in attachment and invasion (Figs. 16, 19, 
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27). Additionally, growth of the pfkA mutant on gluconeogenic carbon sources did not 
restore invasion of this strain. This phenotype suggests that the glycolytic pathway, or 
PfkI itself, is required for virulence.   
The defects in invasion are due principally to reduced production and secretion of the 
effector proteins IpaB and IpaC (Figs. 30, 31).  In the pfkA mutant, expression of virF and 
virB is significantly reduced relative to wild type (Fig. 32).  Expression of virB was also 
reduced in the csrA mutant (data not shown), further supporting the hypothesis that 
carbon metabolism and its regulation is essential for S. flexneri pathogenesis.  Thus, in 
the absence of glycolytic gene expression, S. flexneri does not activate the virulence gene 
cascade necessary for invasion (Fig. 33). 
 Binding of the amphipathic dye Congo red is indicative of S. flexneri virulence.  
Consistent with the invasion defect, both the csrA and pfkA mutants bound less dye 
relative to wild type (data not shown).  Previous data from our lab has shown that 
glycolysis is essential for Congo red binding, as S. flexneri grown on media lacking 
glycolytic carbon sources does not bind the dye (27).   
 Reduced glycolytic gene expression also increased detergent resistance (Fig. 28).  
Reduced effector secretion correlates with increased detergent resistance, as a strain 
defective in Congo red binding was more resistant to SDS versus its Congo red binding 
positive counterpart (53).  Collectively, these data point to a role of glycolysis in 
initiation of S. flexneri pathogenesis, specifically in the synthesis of effector molecules 
and secretion via the type III secreton (Fig. 33).  
Increased glycolytic gene expression in the cra and uvrY mutants correlated with 
increased adherence and invasion (Figs. 15, 16, 24).  The mechanism by which glycolysis 
enhances invasion is unclear. Both the cra and uvrY mutants synthesized and secreted 
wild type levels of effectors (Fig. 31, data not shown).  As the outer membrane affects 
invasion (144), the LPS profile of the cra mutant was also examined. However, there was 
no discernable difference in the outer membrane morphology of the cra mutant as 
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compared to wild type (Fig. A4).  The increased invasion noted in the cra and uvrY 
mutants is likely a result of increased adherence. The factor(s) responsible for S. flexneri 
attachment are unknown, but the process may involve IpaB binding to lipid rafts on the 
host cell membrane (66). However, the absence of Cra had no effect on Ipa production or 
secretion (Figs. 30, 31). Additional factor(s) are also involved in S. flexneri adherence, as 
ipaB null strains are hyperadherent in vitro (50).  Thus, the adhesion phenotypes caused 







Figure 33: Glycolytic gene expression affects S. flexneri physiology and 
pathogenesis. 
The proposed model suggests a mechanism by which disruptions in glycolytic gene 
expression could regulate S. flexneri pathogenesis.  Decreased expression of the 
glycolytic enzyme PfkI alters the lipid A – core region of LPS. However, the specific 
effects of this altered LPS on pathogenesis have not been determined.  PfkI is also 
required for expression of the virulence regulator VirF. Decreased expression of virF 
results in decreased expression of virB and thus decreased production and secretion of 
IpaB and IpaC.  The decreased effector secretion likely influences S. flexneri resistance to 
the detergent SDS.  The mechanism by which increased glycolytic gene expression 
enhances virulence is unclear, but could be due to subtle changes in effector secretion or 
production.   
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2. Persistence in the eukaryotic cytosol requires balanced carbon 
metabolism 
The eukaryotic cytosol is presumably rich in carbon sources, including 
glycerophospholipids, glycoproteins, phosphorylated carbohydrates and glycerol. 
However, microinjection studies suggest that pathogens that occupy this niche have 
specifically adapted to do so (39). Like S. flexneri, Listeria monocytogenes exploits the 
eukaryotic cytosol as a replicative niche. Within this environment, L. monocytogenes 
reduces expression of glycolytic genes, while increasing the pentose phosphate pathway 
(62).  It has been proposed that L. monocytogenes utilizes alternate carbon sources (e.g. 
glycerol and phospholipids) via the pentose phosphate and gluconeogenic pathways. In 
this fashion, the pathogen avoids siphoning valuable resources from the host cell, thereby 
prolonging the integrity of its replicative niche (61).  As Listeria and Shigella both 
occupy the eukaryotic cytosol, it is likely S. flexneri also relies on multiple carbon 
sources to persist within the colonocyte.   
Similar to L. monocytogenes, S. flexneri downregulates expression of key glycolytic 
genes upon entry into the host cytosol, while increasing expression several genes 
involved in glycogen uptake and gluconeogenesis (73). Prolonged occupation of the host 
cytosol may also influence S. flexneri carbon metabolism.  As the number of intracellular 
bacteria increases, it is likely that competition for resources intensifies, mandating that 
the bacteria use a variety of carbon sources to persist.  The ability to use a wide array of 
carbon sources likely relies on catabolite-responsive regulators.  Consistent with this 
prediction, both CsrA and Cra were required for plaque formation by S. flexneri.  
The specific reason for atypical plaque formation by the cra mutant still remains 
unclear, but could stem from several interacting factors. Microscopic examination of the 
cra mutant bacteria within the monolayer showed an increase in the number of bacteria in 
vacuoles and increased formation of microcolonies.  Although these morphological 
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differences may be an artifact of the increased invasion of this strain, they could also 
indicate abnormalities that lead to defects in plaque formation.  The presence of vacuolar 
bacteria may be the result of misregulated effector secretion, as IpaB is required for 
escape from the phagocytic vacuole (50).   A mutation in icsA results in the formation of 
microcolonies, as this mutant is unable to move through the host cytosol.  Despite the 
polar localization of IcsA in the cra mutant (Fig. 17B), the functionality of this protein 
within the host cytosol has not been thoroughly examined.    
Based on the metabolic phenotypes of the cra mutant, misregulation of carbon 
metabolism is likely a significant contributor to aberrant plaque formation by this strain. 
Over a 90-minute period, the strain replicates normally within the eukaryotic cell (data 
not shown). However, the metabolic burden placed on the host cell over a longer period 
of time may lead to defects responsible for the inability of this strain to replicate within 
the monolayer. Data presented in this study show that the cra mutant has increased 
consumption of glycolytic carbon sources, but is defective in utilization of gluconeogenic 
metabolites (Table 5).   The increased number of intracellular bacteria may place a large 
metabolic burden on the host cell. Strict utilization of glycolytic carbon sources could 
result in competition between the cra mutant and its eukaryotic host, increasing 
metabolic stress on the host cell, and may lead to premature death of the host cell.  
Increased glycolysis could also lead to excess acetate production, which is likely toxic to 
the already-stressed host cell.  
Like the cra mutant, the csrA mutant formed smaller, more turbid plaques than wild 
type. However, the abnormal plaque morphology of the csrA mutant is primarily due to 
reduced effector production (Fig. 31). In addition to a role in invasion, the genes encoded 
in the entry locus are necessary for intercellular spread.  
Reduced effector secretion likely impairs the ability of the csrA to invade, and could 
result in delayed activation of the late-stage virulence regulator MxiE. Activity of MxiE 
is also dependent on effector secretion.  IpgC acts as both an intra-bacterial chaperone of 
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IpaB and IpaC and as an activator of MxiE (76).  Thus, reduced effector secretion could 
lead to delays in activation of MxiE, and such delays could decrease the overall rate of 
bacterial spread through the monolayer, resulting in smaller plaques. 
Reduced glycolysis also altered the S. flexneri LPS profile, resulting in a faster 
migrating core (Fig. 29A, C), indicative of changes in the lipid A or core portion of the 
molecule.  There was no detectable difference in the core polysaccharide as determined 
by immunoblotting (Fig. 29C) or novobiocin sensitivity (data not shown).  Thus, it is 
likely that the alteration occurs in the lipid A region. The LPS profile is similar between 
wild type S. flexneri and the avirulent strain SA101 (Fig. 37). Thus, the LPS profile of the 
csrA and pfkA mutants is due to disruptions in carbon metabolism and not a result of 
reduced virulence. The effect of the modified LPS structure on pathogenesis of the 
mutant strains is unknown.  Though lipid A acylation is important for S. flexneri 
pathogenesis in vitro, there are no documented roles of the lipid A region in S. flexneri 
pathogenesis in vitro (26). 
 It is also possible that misregulated carbon metabolism could contribute to plaque 
defects by the csrA mutant. In the phenotypic microarray the csrA mutant preferentially 
utilizes gluconeogenic carbon sources (Table 6), although the shift in metabolism was 
relatively modest.  However, these defects in carbon utilization may result in increased 
competition for resources, as the mutant would be unable to fully utilize the array of 
available carbon sources. The pfkA mutant was completely noninvasive (Fig. 27), and 
thus unable to form plaques.  More studies are needed to better examine the role of 
glycolysis in intracellular survival.  Bowden et al. (16) speculate that increased glycolysis 
is inhibitory to intracellular replication, as expression of pfkA from a plasmid modestly 




3. Carbon metabolism is an environmental regulator of virulence 
gene expression 
 
Environmental conditions in the host induce maximal expression of the plasmid-
encoded virulence genes (Fig. 3).  Temperature (37°C), osmolarity and pH activate 
expression of the transcriptional regulator VirF.  VirF activates the second transcriptional 
regulator VirB, which in turn directly activates the ipa-mxi-spa type III secretion system. 
Carbon metabolism may also be an environmental regulator of virulence gene expression, 
as virF and virB expression was significantly reduced in the pfkA mutant (Fig. 32).   
The mechanism by which carbon metabolism affects virulence gene expression is 
unclear.  There were no canonical CsrA, cAMP-CRP or Cra binding sites identified in 
virF or virB (data not shown). Carbon may therefore affect virulence gene expression in a 
more indirect manner.  Changes in DNA supercoiling play an important role in activation 
of virF and virB expression.  An increase in temperature from 30°C to 37°C results in 
increased supercoiling around the virF (36) and virB (130) promoters.  This shift in DNA 
topology alleviates H-NS-mediated repression, and increases RNA polymerase binding at 
the promoters. Similar to increased temperature, an increase in the [ATP]/[ADP] ratio 
also increases DNA supercoiling (135).  Disruptions in carbon metabolism may affect 
energy production, in turn affecting DNA topology and accessibility of the virF and virB 
promoters.  
The Ipa effectors are required for both invasion and intercellular spread. Prior to 
invasion, S. flexneri upregulates expression of the ipa-mxi-spa type III secretion system.  
However, expression from this entry locus gradually decreases during replication within 
the epithelial cell (46, 73).  Concomitantly, expression of virF and virB also decreases 
(73).  Lucchini et al. (73) propose two scenarios to explain the apparent discrepancy.  
First, the level of effectors needed for intercellular spread may be lower than that needed 
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for invasion, thus accounting for decreased expression of the ipa locus.  Alternatively, 
intracellular Shigella could split into smaller subpopulations.  In this model, one 
population maintains the “invasive” status, and spreads intercellularly.  The other 
subpopulation becomes “dormant”, down-regulating expression of virulence factors (73).   
 Carbon metabolism may be the dividing factor between the two populations. 
Temperature and osmolarity likely remain relatively constant in the intracellular milieu, 
and carbon metabolism may therefore become a primary regulator of virulence gene 
expression.  As Shigella replicates in the host cytosol, competition for available resources 
increases. In response, the bacteria likely utilize alternative carbon sources such as 
glycerol, amino acids and nucleotides. Metabolism of these alternative carbon sources 
would decrease glycolytic metabolism, and in turn decrease expression of virF and virB.  
A small subpopulation, however, may still utilize remaining glycolytic carbon sources, 
thereby retaining the invasive status. Although this model is consistent with the data 
presented, it remains to be experimentally confirmed.  
Disruptions in glycolytic-gluconeogenic carbon flux likely have downstream effects 
on the Entner-Doudoroff and Pentose Phosphate pathways. Thus, it is possible that the 
phenotypes noted in this study are not due directly to changes in glycolysis per se, but 
rather a consequence of altered metabolism via the citric acid cycle, the pentose 
phosphate pathway or the Entner-Doudoroff pathway.   
 As S. flexneri travels the host gastrointestinal tract, the bacterium adapts to several 
distinct environments.  Conditions in the colon, including temperature, pH and osmolarity 
work in concert to maximize expression of the invasion genes. In this fashion, S. flexneri 
coordinates proper location in the host with production of virulence factors.  The data 
presented suggest that carbon source is an additional environmental regulator of the 
invasion genes. Central carbon metabolism involves several connecting pathways, and 
impinges upon a wide array of other cellular processes.  In addition to the glycolytic and 
gluconeogenic pathways, Entner-Doudoroff and Pentose Phosphate pathways may also 
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affect S. flexneri invasion and intracellular survival.  Host-cell metabolism also likely 
affects S. flexneri pathogenesis.  In this study, immortalized Henle cells were used for 
cell culture assays.  Inherent differences in the culture cell line compared to cells in the 
mammalian intestine likely influence the metabolism of invading S. flexneri, as 
differences in host cell physiology could affect the nutrient pool available to S. flexneri.  
The data presented in this study show a strong correlation between central carbon 
metabolism and S. flexneri pathogenesis.  However, future studies are needed to further 






Table A1: BioLog phenotype microarray - Plate 1, 24-hour comparison 







Negative Control  negative control 0.075 0.092 0.062 
L-Arabinose  carbohydrate 0.659 0.448 0.07 
N-Acetyl-D-Glucosamine  carbohydrate 0.798 0.679 0.916 
D-Saccharic Acid  carboxylic acid 0.073 0.084 0.062 
Succinic Acid  carboxylic acid 0.515 0.663 0.358 
D-Galactose  carbohydrate 0.965 0.823 0.537 
L-Aspartic Acid  amino acid 0.57 0.582 0.335 
L-Proline  amino acid 0.064 0.086 0.062 
D-Alanine  amino acid 0.68 0.808 0.067 
D-Trehalose  carbohydrate 1.115 0.808 1.33 
D-Mannose  carbohydrate 0.79 0.817 1.046 
Dulcitol  carbohydrate 0.084 0.101 0.077 
D-Serine  amino acid 0.095 0.094 0.07 
D-Sorbitol  carbohydrate 0.089 0.682 0.076 
Glycerol  carbohydrate 1.085 1.086 0.488 
L-Fucose  carbohydrate 0.075 0.083 0.064 
D-Glucuronic Acid  carboxylic acid 1.188 0.926 0.8 
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D-Gluconic Acid  carboxylic acid 0.209 0.421 0.135 
D,L-a-Glycerol Phosphate  carbohydrate 0.788 0.933 0.794 
D-Xylose  carbohydrate 0.065 0.093 0.073 
L-Lactic Acid  carboxylic acid 1.422 1.521 0.486 
Formic Acid  carboxylic acid 0.079 0.095 0.062 
D-Mannitol  carbohydrate 0.87 0.733 1.024 
L-Glutamic Acid  amino acid 0.103 0.115 0.083 
D-Glucose-6-Phosphate  carbohydrate 1.52 1.388 1.472 
D-Galactonic Acid-g-Lactone  carboxylic acid 0.077 0.082 0.063 
D,L-Malic Acid  carboxylic acid 0.673 0.711 0.428 
D-Ribose  carbohydrate 0.112 0.396 0.064 
Tween 20  fatty acid 0.088 0.103 0.075 
L-Rhamnose  carbohydrate 0.068 0.081 0.068 
D-Fructose  carbohydrate 0.837 0.976 0.674 
Acetic Acid  carboxylic acid 0.066 0.11 0.074 
a-D-Glucose  carbohydrate 0.651 0.698 0.946 
Maltose  carbohydrate 0.087 0.116 0.071 
D-Melibiose  carbohydrate 0.969 1.124 0.121 
Thymidine  carbohydrate 1.278 1.359 1.122 
L-Asparagine  amino acid 0.545 0.783 0.168 
D-Aspartic Acid  amino acid 0.08 0.08 0.064 
D-Glucosaminic Acid  carboxylic acid 0.076 0.088 0.072 
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1,2-Propanediol  alcohol 0.084 0.101 0.071 
Tween 40  fatty acid 0.09 0.095 0.077 
a-Ketoglutaric Acid  carboxylic acid 0.206 0.411 0.103 
a-Ketobutyric Acid  carboxylic acid 0.076 0.11 0.076 
a-Methyl-D-Galactoside  carbohydrate 0.536 0.624 0.085 
a-D-Lactose  carbohydrate 0.085 0.102 0.078 
Lactulose  carbohydrate 0.094 0.114 0.082 
Sucrose  carbohydrate 0.091 0.11 0.075 
Uridine  carbohydrate 0.75 0.523 0.338 
L-Glutamine  amino acid 0.08 0.096 0.067 
m-Tartaric Acid  carboxylic acid 0.055 0.07 0.054 
D-Glucose-1-Phosphate  carbohydrate 1.328 1.243 1.286 
D-Fructose-6-Phosphate  carbohydrate 1.36 1.275 1.414 
Tween 80  fatty acid 0.088 0.107 0.076 
a-Hydroxyglutaric Acid-g-Lactone  carboxylic acid 0.09 0.106 0.08 
a-Hydroxybutyric Acid  carboxylic acid 0.071 0.05 0.065 
b-Methyl-D-Glucoside  carbohydrate 0.078 0.096 0.068 
Adonitol  carbohydrate 0.084 0.093 0.066 
Maltotriose  carbohydrate 0.088 0.11 0.072 
2'-Deoxyadenosine  carbohydrate 1.03 1.499 1.335 
Adenosine  carbohydrate 0.63 1.232 1.091 
Gly-Asp  amino acid 0.416 0.525 0.333 
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Citric Acid  carboxylic acid 0.075 0.086 0.062 
m-Inositol  carbohydrate 0.075 0.084 0.069 
D-Threonine  amino acid 0.078 0.123 0.063 
Fumaric Acid  carboxylic acid 0.624 0.822 0.374 
Bromosuccinic Acid  carboxylic acid 0.42 0.685 0.215 
Propionic Acid  carboxylic acid 0.054 0.058 0.056 
Mucic Acid  carboxylic acid 0.069 0.093 0.07 
Glycolic Acid  carboxylic acid 0.069 0.081 0.066 
Glyoxylic Acid  carboxylic acid 0.063 0.051 0.048 
D-Cellobiose  carbohydrate 0.093 0.111 0.077 
Inosine  carbohydrate 1.417 1.309 1.266 
Gly-Glu  amino acid 0.43 0.262 0.356 
Tricarballylic Acid  carboxylic acid 0.082 0.091 0.072 
L-Serine  amino acid 0.644 0.737 0.449 
L-Threonine  amino acid 0.339 0.246 0.089 
L-Alanine  amino acid 0.814 0.96 0.155 
Ala-Gly  amino acid 0.745 0.918 0.293 
Acetoacetic Acid  carboxylic acid 0.088 0.208 0.068 
N-Acetyl-D-Mannosamine  carbohydrate 0.122 0.196 0.133 
Mono-Methylsuccinate  carboxylic acid 0.165 0.298 0.207 
Methylpyruvate  ester 0.711 0.797 0.493 
D-Malic Acid  carboxylic acid 0.08 0.097 0.063 
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L-Malic Acid  carboxylic acid 0.681 0.717 0.374 
Gly-Pro  amino acid 0.104 0.112 0.077 
p-Hydroxyphenyl Acetic Acid  carboxylic acid 0.078 0.091 0.063 
m-Hydroxyphenyl Acetic Acid  carboxylic acid 0.074 0.087 0.061 
Tyramine  amine 0.073 0.108 0.064 
D-Psicose  carbohydrate 0.077 0.091 0.065 
L-Lyxose  carbohydrate 0.061 0.07 0.056 
Glucuronamide  amide 0.094 0.12 0.169 
Pyruvic Acid  carboxylic acid 0.6 0.789 0.742 
L-Galactonic Acid-g-Lactone  carboxylic acid 0.08 0.089 0.067 
D-Galacturonic Acid  carboxylic acid 1.821 1.904 1.4 
Phenylethylamine  amine 0.078 0.101 0.06 








Table A2: BioLog phenotype microarray, Plate 2, 24-hour comparison 







Negative Control  negative control 0.074 0.087 0.065 
Chondroitin Sulfate C  polymer 0.064 0.069 0.056 
a-Cyclodextrin  polymer 0.107 0.097 0.066 
b-Cyclodextrin  polymer 0.095 0.088 0.069 
g-Cyclodextrin  polymer 0.077 0.084 0.064 
Dextrin  polymer 0.113 0.149 0.068 
Gelatin  polymer 0.082 0.09 0.067 
Glycogen  polymer 0.085 0.086 0.073 
Inulin  polymer 0.081 0.085 0.066 
Laminarin  polymer 0.090 0.097 0.07 
Mannan  polymer 0.085 0.097 0.075 
Pectin  polymer 0.143 0.143 0.11 
N-Acetyl-D-Galactosamine  carbohydrate 0.085 0.099 0.066 
N-Acetyl-Neuraminic Acid  carboxylic acid 1.115 1.044 1.046 
b-D-Allose  carbohydrate 0.070 0.071 0.058 
Amygdalin  carbohydrate 0.080 0.093 0.062 
D-Arabinose  carbohydrate 0.076 0.084 0.062 
D-Arabitol  carbohydrate 0.084 0.087 0.067 
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L-Arabitol  carbohydrate 0.076 0.093 0.065 
Arbutin  carbohydrate 0.081 0.085 0.061 
2-Deoxy-D-Ribose  carbohydrate 0.058 0.063 0.056 
i-Erythritol  carbohydrate 0.086 0.083 0.069 
D-Fucose  carbohydrate 0.085 0.09 0.073 
3-0-b-D-Galactopyranosyl-D-Arabinose  carbohydrate 0.054 0.06 0.054 
Gentiobiose  carbohydrate 0.086 0.09 0.069 
L-Glucose  carbohydrate 0.084 0.078 0.068 
D-Lactitol  carbohydrate 0.082 0.101 0.072 
D-Melezitose  carbohydrate 0.088 0.08 0.068 
Maltitol  carbohydrate 0.088 0.096 0.071 
a-Methyl-D-Glucoside  carbohydrate 0.093 0.089 0.066 
b-Methyl-D-Galactoside  carbohydrate 0.096 0.097 0.084 
3-Methylglucose  carbohydrate 0.098 0.129 0.091 
b-Methyl-D-Glucuronic Acid  carboxylic acid 0.092 0.101 0.072 
a-Methyl-D-Mannoside  carbohydrate 0.095 0.103 0.077 
b-Methyl-D-Xyloside  carbohydrate 0.086 0.103 0.078 
Palatinose  carbohydrate 0.104 0.128 0.088 
D-Raffinose  carbohydrate 0.804 0.759 0.07 
Salicin  carbohydrate 0.072 0.086 0.079 
Sedoheptulosan  carbohydrate 0.079 0.088 0.067 
L-Sorbose  carbohydrate 0.081 0.082 0.063 
141 
 
Stachyose  carbohydrate 0.086 0.096 0.071 
D-Tagatose  carbohydrate 0.090 0.093 0.079 
Turanose  carbohydrate 0.100 0.14 0.094 
Xylitol  carbohydrate 0.088 0.094 0.075 
N-Acetyl-D-glucosaminitol  carbohydrate 0.104 0.121 0.077 
g-Amino-N-Butyric Acid  carboxylic acid 0.093 0.106 0.077 
d-Amino Valeric Acid  carboxylic acid 0.103 0.123 0.087 
Butyric Acid  carboxylic acid 0.097 0.097 0.09 
Capric Acid  carboxylic acid 0.082 0.067 0.054 
Caproic Acid  carboxylic acid 0.073 0.099 0.066 
Citraconic Acid  carboxylic acid 0.067 0.097 0.058 
D,L-Citramalic Acid  carboxylic acid 0.085 0.089 0.074 
D-Glucosamine  carbohydrate 1.294 1.048 1.003 
2-Hydroxybenzoic Acid  carboxylic acid 0.055 0.061 0.047 
4-Hydroxybenzoic Acid  carboxylic acid 0.071 0.089 0.057 
b-Hydroxybutyric Acid  carboxylic acid 0.084 0.106 0.078 
g-Hydroxybutyric Acid  carboxylic acid 0.095 0.081 0.087 
a-keto-valeric acid  carboxylic acid 0.085 0.09 0.076 
Itaconic Acid  carboxylic acid 0.069 0.071 0.065 
5-Keto-D-Gluconic Acid  carboxylic acid 0.086 0.094 0.07 
D-Lactic Acid Methyl Ester  ester 0.133 0.114 0.088 
Malonic Acid  carboxylic acid 0.089 0.093 0.068 
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Melibionic Acid  carbohydrate 0.771 0.899 0.1 
Oxalic Acid  carboxylic acid 0.090 0.096 0.067 
Oxalomalic Acid  carboxylic acid 0.093 0.106 0.074 
Quinic Acid  carboxylic acid 0.077 0.082 0.065 
D-Ribono-1,4-Lactone  carboxylic acid 0.095 0.096 0.072 
Sebacic Acid  carboxylic acid 0.067 0.069 0.06 
Sorbic Acid  carboxylic acid 0.047 0.052 0.048 
Succinamic Acid  carboxylic acid 0.270 0.228 0.22 
D-Tartaric Acid  carboxylic acid 0.068 0.075 0.072 
L-Tartaric Acid  carboxylic acid 0.072 0.079 0.065 
Acetamide  amide 0.081 0.092 0.068 
L-Alaninamide  amide 0.095 0.107 0.078 
N-Acetyl-L-Glutamic Acid  amino acid 0.093 0.102 0.072 
L-Arginine  amino acid 0.081 0.087 0.063 
Glycine  amino acid 0.091 0.105 0.067 
L-Histidine  amino acid 0.080 0.098 0.065 
L-Homoserine  amino acid 0.084 0.087 0.071 
Hydroxy-L-Proline  amino acid 0.078 0.098 0.065 
L-Isoleucine  amino acid 0.082 0.092 0.068 
L-Leucine  amino acid 0.085 0.096 0.068 
L-Lysine  amino acid 0.083 0.089 0.065 
L-Methionine  amino acid 0.085 0.083 0.067 
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L-Ornithine  amino acid 0.075 0.083 0.059 
L-Phenylalanine  amino acid 0.085 0.089 0.064 
L-Pyroglutamic Acid  amino acid 0.087 0.091 0.065 
L-Valine  amino acid 0.084 0.09 0.069 
D,L-Carnitine  carboxylic acid 0.084 0.089 0.066 
Sec-Butylamine  amine 0.082 0.083 0.066 
D,L-Octopamine  amine 0.079 0.081 0.066 
Putrescine  amine 0.075 0.087 0.061 
Dihydroxyacetone  alcohol 0.067 0.069 0.065 
2,3-Butanediol  alcohol 0.094 0.097 0.077 
2,3-Butanone  alcohol 0.080 0.096 0.069 






Figure A1: Invasion of pfkA grown on gluconeogenic carbon sources. 
 
Strains were grown overnight in minimal media supplemented with 0.2% pyruvate.  
Overnight cultures were diluted to an optical density (A650) of 0.03 in MOPS media 
supplemented with 0.2% carbon source and grown to exponential phase at 37°C with 
aeration.  Equal numbers of cells (2x108) were used in the invasion assay. Data are from 
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Figure A2: LPS profiles of intracellular bacteria. 
 
Strains were grown to exponential phase in LB broth at 37°C, and 1x109 cells from the 
culture were used to prepare the pre-invasion (LB broth) LPS. Approximately 5x109 cells 
from the culture were spun onto confluent monolayer of confluent Henle cells.  After a 30 
minute incubation, uninvaded bacteria were collected from the media and used to prepare 
the “extracellular” LPS sample. Monolayers were overlayed with media containing 
gentamycin, and incubated an additional two hours.  Intracellular bacteria were then 









Figure A3: Protein profile of S. flexneri growing inside the host cytosol. 
 
Whole cell lysates from bacteria grown in LB broth, or extracellular and intracellular 
bacteria were electrophoresed on an SDS-PAGE gel and silver stained (A).  The 
intracellular proteins were then transferred to a nitrocellulose membrane and probed with 




Figure A4: LPS profile of SA101 (vir-). 
Strains were grown to exponential phase in LB broth, and approximately 109 cells were 
collected by centrifugation. Cells were lysed by boiling, and the cell lysate was treated 
with proteinase K.  LPS was separated on a tricine SDS-PAGE gel, and visualized by 
silver staining. SA101 (vir-) is an avirulent S. flexneri 2a strain. rfaX (SA555-148, 
renamed waaJ) is defective the addition of two glycose residues to the outer core of LPS, 
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